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Endometriosis is the presence of endometrial-like tissue outside the uterus, which 
induces a chronic, inflammatory reaction. It is a common and debilitating 
gynaecological condition, which may cause severe pain, significant impairment of 
quality of life and infertility.  
 
Non-invasive techniques to establish the presence and severity of pelvic 
endometriosis would be valuable to patients in a number of ways: to guide patient 
choice regarding treatment; to plan fertility or medical treatment; to enable referral to 
the most appropriate centre and surgeon if surgery is chosen; to enable pre-operative 
counselling; and better plan the operation including the involvement of other 
specialties as indicated. 
 
This thesis aims to assess: the ability of ultrasound to pre-operatively predict the 
presence and severity of pelvic endometriosis; the reproducibility of these findings; 
the benefit of tenderness mapping, symptomatology and serum CA125 measurement 
both on their own and in addition to ultrasound.   
 
The introduction to this thesis discusses: the pathogenesis and impact of 
endometriosis; the literature regarding the diagnostic tests available including MRI 
and ultrasound; and the usefulness of serum markers.  
 
Study one assesses the reproducibility of the assessment of severity of pelvic 
endometriosis by transvaginal ultrasound.  Study two assesses the accuracy of the 
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ultrasound diagnosis of the specific features of pelvic endometriosis and assesses the 
impact on the diagnostic accuracy of lesion location and total number of lesions.  
Study three assesses the ability of ultrasound to accurately assess the overall severity 
of pelvic endometriosis and therefore to enable preoperative triaging of patients.  
Study four assesses if symptoms alone or in combination with the ultrasound findings 
are diagnostically useful.  In addition, tenderness mapping is assessed as an addition 
to the ultrasound findings.  Lastly, in study five CA125 is assessed as a test for 
endometriosis on its own and as an addition to the ultrasound findings.    
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Chapter 1: Introduction 
 
1.1 Introduction  
Endometriosis is a disease defined as the abnormal location of tissue similar to the 
lining of the uterus (endometrium)1.  This is usually confined to the pelvis and is 
associated with painful periods, pelvic pain, reduced fertility and pain during sexual 
intercourse.  
 
Endometriosis is a common condition but the prevalence of this condition in the 
general population is uncertain, as to date surgery is required as the gold standard for 
diagnosis. Amongst women undergoing surgery the prevalence of endometriosis 
varies widely depending on the indication for the operation. The reported prevalence 
varies from 40 to 60% in women with dysmenorrhea, and 20 to 30% in women being 
investigated for subfertility2.  Endometriosis is detected in 2–50% of laparoscopies 
done in women with no symptoms (e.g. in a context of tubal ligation), whilst among 
those undergoing abdominal hysterectomy, it can be as high as 25%3.  
 
1.2 Clinical presentation  
Patients with endometriosis present with a range of clinical symptoms.  The classical 
presentation is with pain before or during menstruation and pain during sexual 
intercourse.  Many women however do not present with these symptoms.  Some may 
have abdominal distension or bloating and pain not related to the menstrual cycle.  
This creates diagnostic challenges for the gynaecologist, as there are many other 
conditions such as irritable bowel and pelvic inflammatory disease that can present in 
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very similar ways.  Also, as described above, some patients can have endometriosis 
found at laparoscopy for either laparoscopic sterilisation or as part of the investigation 
for infertility when they are completely pain free.  
 
1.3 Pain pathways 
The simplest way to describe pain conduction pathways from the viscera to the brain 
is that nociceptors transmit signals to the spinal cord via primary afferent nerve fibres 
and the painful stimulus is then transmitted to the brain and the sensation of pain is 
experienced by the person.  However, painful sensations are subject to a series of 
modulatory mechanisms which can occur in the spinal cord via descending fibres or 
via pharmacological agents. At each ascending neurological level pain sensation is 
influenced by modulatory activity including mental state such as anxiety, prior 
sensitisation, stress, life events, the individuals understanding of the causes of pain 
and social conditioning.  All of these factors create highly complex interaction 
between the pathological process and the person who perceives the pain4.  
 
1.4 Types of disease 
It has been proposed that pelvic endometrosis is three separate, but related disease 
entities5:  superficial peritoneal, ovarian endometriomas and deeply infiltrating 
disease (DIE).  There are likely to be different underlying mechanisms involved in the 
development of these different disease states. These mechanisms will be discussed in 





1.5 Diagnosis and staging of endometriosis at laparoscopy 
Currently, laparoscopy is the gold standard for the diagnosis and staging of 
endometriosis. Diagnostic laparoscopy is associated with 0.06% risk of major 
complications (e.g. bowel perforation) whilst this risk is increased to 1.3% in 
operative laparoscopy6.   Repeated laparoscopies increase the operative risks due to 
scarring and adhesions. 
The revised American Society of Reproductive Medicine7 (rASRM) staging system 
for the operative diagnosis of endometriosis is a weighted scoring system which takes 
into account all the features of pelvic endometriosis.  Features include superficial and 
deep ovarian and peritoneal endometriosis, extent of pouch of Douglas obliteration, 
density and degree of enclosure of the ovaries and tubes by adhesions and any other 
evidence of bowel or urinary tract endometriosis.  The benefit of this system is that it 
is a systematic objective standardised approach to the findings at surgery and the 
staging of the disease.  Below is the scoring system as published in 19857.  
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Figure 1. Revised American Society of Reproductive Medicine staging of pelvic 





As can be seen from the above guidelines deeply invasive endometriosis (DIE), in 
isolation, can score a maximum of 6 points even if invading into bowel. Thus it is 
possible for DIE to be scored as mild disease when a bowel resection would be 
required to excise this disease.  This type of operation would carry a significant 
operative risk. The deficiency of this system is a reflection of the fact that the scoring 
relates to how the disease is likely to affect fertility.   Any updated scoring system for 
endometriosis should include the operative risk together with the impact on future 
fertility.  
 
1.6 Alternative imaging modalities to ultrasound for the diagnosis of 
pelvic endometriosis. 
Computerised Tomography (CT) gives reasonable quality images of the bowel but is 
poor at identifying other soft tissue structures and there is a considerable amount of 
radiation involved, especially when the pelvis is being assessed. For this reason 
magnetic resonance imaging (MRI) is now the preferred alternative to CT.  When the 
patient is starved for 6 hours prior to examination and a smooth muscle relaxant is 
administered reasonable quality images of bowel can be obtained on MRI.  In 
addition high quality images of the uterus, adnexa, vagina, bladder and upper urinary 
tract can be obtained.  This enables visualisation of the whole pelvis in one 
examination. Although static images can not give any information regarding pelvic 
organ mobility or tenderness, because of the intense desmoplastic reaction and 
fibrosis that is often seen around areas of DIE, such as to the uterus and adnexa, these 
distortions in pelvic anatomy can be seen on MRI.  Other signs of adhesions on MRI 
include triangular tenting and fluid collections. Retraction of the ovaries from the 
ovarian fossa towards the midline is usually seen in deep pelvic endometriosis8.  
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On MRI, colonic endometriotic implants appear as areas of irregular wall thickening 
or low signal intensity plaques on the T2 images, and are sometimes associated with 
hemorrhagic foci that are hyperintense on fat suppressed T1 images8 (T1 and T2 are 
settings on the MRI machine which give different levels of contrast and signal 
intensity between various tissue types). Other areas appear as hypo or hyper intense 
foci with morphological abnormalities such as stellate margins9.   
 
When MRI was a relatively new imaging modality the quality of the images and the 
knowledge of the morphological changes resulted in a relatively low accuracy for 
detecting extra-ovarian disease. In 1989 Arrive10 used MRI to assess 30 women  with 
clinically suspected endometriosis and compared this with the surgical findings. Three 
of the five normal cases and 16 of the 25 cases of endometriosis were correctly 
identified with MRI (sensitivity, 64%; specificity, 60%; accuracy, 63%). MRI  
demonstrated seven of eight endometriomas but only 14 of 29 adhesions and only six 
of 45 endometrial implants. They concluded that MR imaging could not be used as 
the primary modality in the detection, characterization, and staging of endometriosis.   
In the same year Zawin11 found a slightly better sensitivity of 71% and specificity of 
82% for the MRI detection of pelvic endometriosis but also concluded that it could 
not be used as a first line investigation.  
 
Kinkel in 199912 assessed with MRI 30 women who had proven endometriosis to 
establish the morphological features of the various locations of DIE. They found that 
proximal nodularity was different for uterosacral ligaments with deep endometriosis 
but there was no difference in signal intensity between normal and abnormal 
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uterosacral ligaments. They also found that rectal endometriosis was missed in two of 
three patients and showed non-specific rectal wall thickening in one patient. It was 
concluded that MR imaging can diagnose deep endometriosis of uterosacral 
ligaments, the bladder and the pouch of Douglas, but lacks sensitivity in detecting 
rectal endometriosis without rectal distension. 
 
Bazot9 in 2004 compared MRI and endometriosis found at surgery and found that the 
sensitivity, specificity and accuracy of MR imaging for deep pelvic endometriosis 
were 90.3%, 91%, and 90.8% respectively.  The sensitivity, specificity, and accuracy, 
respectively, of MR imaging for the diagnosis of endometriosis in specific sites were 
as follows: USL, 76%, 83.3% and 80.5%; vagina, 76%, 95.4%, and 93.3%; 
rectovaginal septum, 80%, 97.8%, and 96.9%; rectosigmoid, 88%, 97.8%, and 94.9%; 
and bladder, 88%, 98.9%, and 97.9%. They conclude that MRI demonstrates high 
accuracy in prediction of deep pelvic endometriosis in specific locations.  However, 
this study was performed in a major Parisian teaching hospital with the images being 
read by a radiologist with a specialist interest in endometriosis diagnosis and the 
patient population was of women being referred for specialist endometriosis surgery 
with an ultrasound diagnosis of endometriosis already.  For this reason the results 
may be superior to those seen in everyday practice.   
 
There have been various studies related to differing modes of ultrasound compared 
with MRI for the assessment of the specific locations of DIE.  Bazot13 in 2007 
compared the accuracy of MRI and rectal endoscopic sonography (RES) for the 
evaluation of DIE in 88 patients.  Their results showed a sensitivity and specificity of 
MRI and RES, respectively, of 84.8% and 45.6%, 88.8% and 40%, for uterosacral 
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endometriosis; 77.7% and 7.4%, 70% and 100%, for vaginal endometriosis and 88.3 
and 90%, 92.8 and 89.3 for colorectal endometriosis. Their conclusion was that MRI 
is more accurate than RES for the diagnosis of uterosacral and vaginal endometriosis, 
whereas the two methods are similarly accurate for colorectal endometriosis. 
 
Bazot14 in 2008 went on to compare physical examination, transvaginal sonography, 
RES and MRI for the diagnosis of DIE in 92 patients with clinically suspected 
endometriosis.  They found that MRI performs similarly to TVS and RES for the 
diagnosis of intestinal endometriosis but has higher sensitivity and likelihood ratios 
for uterosacral ligament and vaginal endometriosis. They also found that clinical 
examination can detect deep endometriosis in 81.5% of cases but that the localisation 
of disease was poor with much greater accuracy on the other imaging modalities.  
 
Grasso15 in 2009 compared three dimensional transvaginal ultrasound with MRI and 
found that the sensitivity and specificity of MRI for the diagnosis of deep infiltrating 
endometriosis in specific sites were: USL 69.2% and 94.3%; vagina 83.3% and 
88.8%; rectovaginal septum 76.4% and 100%; rectosigmoid 75% and 100%; bladder 
83.3% and 100%.  This compares values for 3D TVS of : USL 50% and 94.7%; 
vagina 84% and 80%; rectovaginal septum 76.9% and 100%; rectosigmoid 33.3% and 
100%; bladder 25% and 100%.  This shows that the 3D TVS has lower sensitivities 
than MRI but similarly high specificities.  However this study was performed in only 
33 patients of whom only 66% had DIE and therefore further investigation with larger 
studies are needed to validate these findings.  
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The main criticism of MRI is that it is less readily available and significantly more 
expensive than ultrasound examination.  For this reason MRI is usually reserved as a 
second line imaging modality.  
 
1.7 Ultrasound diagnosis of endometriosis 
Transvaginal ultrasound has been reported to be a safe, non invasive investigation and 
has been shown to have a high degree of accuracy in the detection and exclusion of 
ovarian endometriomas (cysts on the ovary containing endometrium)16.  However, 
when this thesis was conceived there were no prospective studies confirming the 
accuracy of transvaginal ultrasound for the diagnosis of non-ovarian endometriosis.   
Since then there have been a number of prospective studies detailing the accuracy of 
the diagnosis of deeply infiltrating disease.  The transrectal and transvaginal 
ultrasound assessment of endometriosis will be considered in sections 1.8 and 1.9 
respectively.  
 
1.8 Transrectal ultrasound diagnosis of endometriosis.  
In contrast there have been various studies assessing the use of endorectal ultrasound 
in the assessment of rectovaginal septum and uterosacral ligament endometriosis17-20. 
Ohba20 in 1996 performed transrectal ultrasound examination on patients after a 
laparoscopic diagnosis of uterosacral ligament endometriosis and found that this 
showed thick and irregularly shaped uterosacral ligaments. Normal uterosacral 
ligaments appeared as low echoic homogeneous arcs on each side of the uterine 
cervix.   They measured the diameter of the uterosacral ligaments and found that the 
patients who had endometriosis affecting the ligaments had diameters that were 
significantly thicker than the normal ligaments (P<0.05).  They also found that the 
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patients with endometriosis were more likely to have tenderness on palpation of the 
uterosacral ligaments if the diameter was >14mm.  This possibly suggests that more 
advanced infiltration gives rise to more symptoms.   However, as the ligaments were 
not biopsied, it is not confirmed that the thickening was due to endometriosis 
infiltration.  Also this study was attempting to show that there are differences that it is 
possible to detect on transrectal ultrasound.  No attempt was made to assess the 
accuracy of the diagnosis by this method. 
 
In a retrospective study by Chapron18 in 1998 rectal endoscopic ultrasonography 
showed deep invasion of the bowel mucosa in all 16 patients who underwent 
laparotomy with bowel resection. The histological results confirmed in each of these 
16 patients (100%) that there was deep infiltration of the intestinal wall by 
endometriotic lesions.  This study can be criticised as being retrospective and 
therefore open to bias.  However, the findings open the possibility of assessing 
preoperatively which patients could have their endometriosis treated without opening 
the bowel and which would need a full bowel resection.   
 
In a study by Griffiths17 in 2008 transrectal ultrasound for the diagnosis of deeply 
invasive endometriosis the positive likelihood ratio was 10.89 and the negative 
likelihood ratio was 0.24 suggesting a high degree of accuracy. However this study 
does not state whether it was pro or retrospective and it was not clear whether the 
patients had previously had a diagnosis of endometriosis made at laparoscopy. These 
findings suggest that transrectal ultrasonography may have a high degree of accuracy 
for the diagnosis of bowel endometriosis. However prospective observational studies 
are necessary to validate these findings. 
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Although these studies suggest a high degree of accuracy for transrectal 
ultrasonography for all these studies the patients had enemas as preparation.  This is 
given to empty the bowel and induces diarrhoea, which is quite unpleasant for the 
patient.  Some patients also find the procedure so unpleasant that sedation or even 
general anaesthetic is sometimes required.  In addition a circumferential rectal probe 
was used which does not allow for accurate visualisation of the other pelvic organs 
such as the bladder, uterus and ovaries. In order to study the other pelvic organs an 
alternative imaging modality would have to be used such as tranvaginal ultrasound or 
MRI.  
 
In 2003 Bazot21 compared rectal endoscopic sonography (RES) with transvaginal 
ultrasound (TVS).  They took 30 patients and preoperatively assessed them for signs 
of deeply infiltrating endometriosis.  They found that the sensitivity and specificity of 
TVS and RES for the diagnosis of uterosacral ligament involvement was 75% and 
75%, and 83% and 67% respectively.  For the diagnosis of rectosigmoid 
endometriosis the results were 95% and 82%, and 100% and 88% respectively.   They 
conclude that the results of TVS are similar to those possible with RES and therefore 
TVS should be used at first line assessment.  They state that one of the advantages of 
RES is that the frequencies used are often higher than the TVS transducers and 
therefore give good detail analysis of the bowel mucosa but poor penetration of 
surrounding structures.  This explains why it is difficult to assess the bladder or 
anterior structures of the pelvis.  For this reason TVS gives a broader assessment of 
the pelvis.  They state that this is the first study to assess the use of TVS for rectal 
lesions.  TVS will be discussed in more detail in the next section  
 28 
 
1.9 Studies assessing the role of transvaginal ultrasound assessment of extra- 
ovarian endometriosis. 
As seen in section 1.8 non- ovarian endometriosis features such as uterosacral 
ligament involvement were first assessed on transrectal sonography (TRS)20 in 1996.  
In 1998 another study by Chapron18 suggested that rectal endoscopic sonography 
(RES) was useful for the diagnosis of intestinal endometriosis.   
 
In 2002 Ballyguier22 compared MRI and TVS for the diagnosis of DIE.  They found 
that TVS was good at locating bladder lesions but was less good than MRI at 
detecting rectal and posterior lesions.   However, this was a retrospective study and 
only included 12 patients, all with histologically proven endometriosis of the bladder.  
Their conclusions were likely to be biased because of these drawbacks. 
 
In 2003, Bazot et al21 demonstrated that TVS was as accurate as RES for the 
diagnosis of intestinal endometriosis and may provide useful information for 
assessing uterosacral ligament endometriosis.   This study is discussed in relation to 
RES in section 1.7.  However, it was the first study to assess TVS in the diagnosis of 
rectal endometriosis involvement. In 2004 the same group went on to prospectively 
assess the role of TVS in 142 women when compared with laparoscopy and histology.  
They found that the sensitivity and specificity of TVS for the diagnosis of DIE of the: 
bladder 71.4% and 100%; uterosacral ligaments (USL) was 70.6% and 95.9%; vagina 
was 29.4% and 100%; rectovaginal septum was 28.6 and 99.3%;  and for interstinal 
disease 87.2% and 96.8% respectively.  They concluded that the assessment of 
bladder and intestinal disease was accurate but the assessment of uterosacral, vaginal 
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and rectovaginal septum involvement was less accurate.   They noted that retroflexion 
of the uterus,  subserous fibroids and endometriotic ovarian cysts which were 
adherent to the uterosacral ligaments can obscure the ligaments and therefore make 
them difficult to visualise on TVS.    They also note that in the assessment of rectal 
and intestinal disease TVS can not give a distance from the rectal lesion to the anal 
margin.  TVS is also restricted in the ability to assess the sigmoid colon due to 
distance and the presence of faecal matter.    
 
Bazot23 repeated the comparison between TVS and RES in 2007 and found that the 
accuracy of TVS had improved and the sensitivity for the diagnosis of USL disease 
was 80.8%.    TVS was now better than RES for all areas except intestinal disease.  
This improvement may have been due to variations in the populations between these 
studies or to improved technique with greater experience.  However,  the authors 
reaffirm that TVS should be the first line imaging modality of choice.  
 
Abrao24 in 2007 compared the use of bimanual examination, TVS and MRI for 
detection of DIE of the rectosigmoid and/or ‘retrocervical sites’ as defined by the 
author in 104 patients, demonstrating higher sensitivity, specificity, NPV and PPV for 
TVS in cases of rectal DIE when compared with MRI and clinical examination. 
However, it is not clear whether radical resection of diseased tissue, including rectal 
resection and/or dissection of POD obliteration by adhesions, was performed in all 




Hudelist25 in 2009 studied the additional benefit of TVS with clinical examination in 
200 women.  They found that the sensitivity of per vaginum (PV) examination was 
23% for left ovary, 38% for right ovary, 52% for right USL, 74% for left USL, 25% 
for bladder,  46% for rectum, 64% for vagina, 70% for pouch of Douglas, and 88% 
for rectovaginal septum.  The specificities were all above 98% except for left USL 
which was 89%.  With the addition of TVS to the PV exam the sensitivities improved 
to over 80% except for bladder of which was 75% and right USL of 67%.  The 
specificities were maintained at their high level.  These patients were all examined by 
senior gynaecologists who all work in a tertiary endometriosis centre and therefore 
their PV examination skills would be at a very high level.  Even in this context the 
accuracy was improved by the addition of ultrasound examination and therefore it is 
likely that the benefit of TVS would be greater for less experienced clinicians.    
 
Hudelist26 then went on to compare TVS and PV exam directly and found that TVS 
was much more accurate than PV exam especially for ovarian endometriomas and 
rectosigmoid disease. In 27 women with proven endometriomas, vaginal examination 
yielded a sensitivity of only 41%, in contrast to the finding obtained by TVS with a 
sensitivity of 96%. These differences were less obvious for the rectovaginal space or 
vaginal deep infiltrating endometriosis with lower sensitivities and NPVs for both 
modalities when compared with values for ovarian or rectosigmoidal endometriosis. 
The largest difference between TVS and PV exam was for the detection of 
rectosigmoidal endometriosis. In this study, 31 women (24.0%) had rectosigmoidal 
deep infiltrating endometriosis, of which 39% were preoperatively diagnosed by PV 
exam and 90% of them by TVS. The authors explain the obviously lower sensitivity 
and accuracy of vaginal examination by two factors. First, rectosigmoidal 
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endometriotic nodules situated at or above the level of the uterine fundus cannot be 
palpated digitally but can be visualized by TVS. Second, it is difficult to assign 
palpable nodules situated posterior to the cervix to specific anatomical structures such 
as the uterosacral ligaments, rectovaginal septum, vagina, rectum or sigmoid.  This 
causes false-negative findings with regard to rectal or sigmoid deep infiltrating 
endometriosis. By contrast, TVS clearly facilitates the differential visualization and 
possible endometriotic involvement of these locations.  
 
There are few studies on the accuracy of TVS for the diagnosis of ovarian adhesions 
either due to endometriosis or to other causes. No study has previously assessed 
mobility as either minimal, moderate or severe adhesions for the ovary in accordance 
with the ASRM classification7.  Guerriero et al27 used the combination of 3 features as 
suggestive of ovarian adhesions: blurring of the ovarian margin, the inability to 
mobilise the ovary on palpation (fixation) and an increased distance from the probe.  
They found that these tests either combined or individually gave a kappa value of 
between 0.25 and 0.51.  Okaro28 examined women with chronic pelvic pain prior to 
laparoscopy for the presence of ovarian adhesions and classified them as either 
mobile or fixed.  They found a high degree of agreement between TVS and 
laparoscopy at identifying ovarian adhesions (0.81 kappa). Yazbek29 examined the 
role of ultrasound for the preoperative assessment of adnexal masses.  They found a 
sensitivity of 44% and a specificity of 98% in the diagnosis of severe pelvic 
adhesions. Guerriero30 used a technique of applying pressure between the uterus and 
ovary. If they remained linked then this was suggestive of adhesions. This gave a 
sensitivity and specificity of 89% and 90% respectively for fixation of the ovaries to 
the uterus.   
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The preoperative diagnosis of partial or complete obliteration of the pouch of Douglas 
has not been reported on directly before.  Hudelist25 gave a high accuracy for the 
diagnosis of pouch of Douglas endometriosis but did not report obliteration 
separately. Yazbek29 described the technique for diagnosing POD obliteration but did 
not report this finding separately from severe pelvic adhesions.  
 
The assessment of adhesions is important preoperatively as surgery for severe 
adhesions carries a higher risk of complication and therefore needs to be performed 
by more experienced surgeons.  The patients may also decide that their symptoms are 
not severe enough to warrant surgery. Therefore the accurate preoperative assessment 
will help in counselling patients regarding the best treatment option for them. 
 
No studies have yet assessed the role of transvaginal ultrasound for the severity of 
endometriosis compared with the ASRM staging system. In addition, no studies have 
assessed the interobserver variability of transvaginal ultrasound for the diagnosis of 
the severity of pelvic endometriosis. 
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Summary table of the important imaging studies with comparison of methods 
(reproduced from Nightingale, Ballard and Wright 2012 Gynaecological Surgery with 
permission) 
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endometriosis transducer combined 
with bimanual PV 
examination within 
2months of surgery. 
No rectal enema 
used 
the same examiner 
Menada  2006–
2007 
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Summary table of study results: imaging of rectal or recto-sigmoid involvement in 
deep infiltrating endometriosis (reproduced from Nightingale, Ballard and Wright 
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*Pre-test probability is the prevalence of deep infiltrating endometriosis 
involving the rectum or rectosigmoid colon. 
**Figures published in the paper given, no data were available to 
construct a 2 × 2 table in order to calculate 95% confidence intervals 




1.10 Surgical treatment of endometriosis. 
The success of surgery for pelvic endometriosis is highly dependent on the expertise 
and training of the operating surgeon31.  In an attempt to optimise the treatment of 
women suffering from severe endometriosis, tertiary referral endometriosis centres 
have been established32 (RCOG green top guideline). These centres provide 
comprehensive care to endometriosis patients including high quality surgical care. 
The capacity of tertiary centres, however, is limited and the critical issue in routine 
clinical practice is the ability to assess the severity of endometriosis in order to 
facilitate the triaging of women for treatment. In cases of mild and moderate 
endometriosis, treatment can be provided immediately, even when the operation is 
performed by non-expert laparoscopic surgeons. In cases of severe disease, however, 
treatment cannot be provided unless the surgeon has significant laparoscopic skills in 
the surgical excision of endometriosis32-34. This is especially important if the disease 
involves the rectovaginal septum as this can extend anteriorly into the vagina, 
posteriorly into the rectum and laterally to effect the ureters.  Laparoscopy is 
associated with surgical and anaesthetic risks, and it is very costly compared to non-
invasive diagnostic methods. A non-invasive method, which would enable a reliable 
diagnosis of severe endometriosis, could facilitate early referral to tertiary 
endometriosis centres or to local surgeons with special interest and skills in 
laparoscopic surgery for endometriosis. In chapter 8 we examine the ability of 
preoperative transvaginal ultrasound to assess the severity of pelvic endometriosis 
when compared with the findings at laparoscopy. The aim of the study was to 
establish whether pre-operative ultrasound examination is an accurate method to 
diagnose severe pelvic endometriosis.  
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Chapter 2: Pathophysiology of endometriosis. 
2.1 Pathophysiology of endometriosis. 
The natural history of endometriosis is not well understood and there are no non-
invasive studies regarding the natural history of this disease.  Risk factors for 
endometriosis include early menarche and late menopause. In contrast the use of the 
oral contraceptive pill, which suppresses menstruation, is protective. These findings 
suggest that the development of disease seems to be related to exposure to 
menstruation35,36. The exact aetiology is not well understood and several theories have 
been proposed.  
 
2.2 Retrograde menstruation 
This remains the foremost theory and was first proposed by Sampson in 192736. He 
postulated that endometrial tissue is deposited in the peritoneal cavity via retrograde 
flow through the fallopian tubes during menstruation. These cells then adhere, invade 
and proliferate within the structures of the peritoneal cavity. 
 
Animal studies have shown that adhesion occurs when endometrial tissue from 
baboons, mice and humans is transplanted into the peritoneal cavity37.  Stromal 
endometrial cells have a high level of VEGF (vascular endothelial growth factor), 
which suggests an active vascular network is necessary for graft survival and 
implicates them in graft attachment. Glandular cells have a high proliferation rate in 
freshly-implanted endometriotic lesions, suggesting a more prominent role for these 
cell types in graft growth38.  Stromal cells may contribute to adhesion via secretion of 
extracellular matrix components and the endocrine environment is likely to play a role 
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in this activity. Additionally, IL-6 and TNF-alpha have been show to increase 
endometrial cell adhesion to the peritoneum in mice37. 
 
The theory of transplantation via retrograde menstruation is supported by evidence 
that endometriosis is more common in adolescents with obstructive outflow 
reproductive tract anomalies39. It is also supported by the fact that dependent areas of 
the pelvis, where pooling of menstrual effluent occurs, are more likely to be 
affected40. However it is unclear whether retrograde menstuation occurs more 
frequently in women with endometriosis than in those without. The presence of 
retrograde menstruation has been described as being between 76 and 90% of women 
investigate with laparoscopy38,41. In one of these studies41 the presence of retrograde 
menstruation was higher (97%) in women with endometriosis than in those without.  
However in the other study38 no difference was found. The transplantation theory 
plausibly explains peritoneal endometriosis but does not adequately explain deeply-
infiltrating, ovarian or distant site disease.   
 
2.3 Epithelial transformation 
Meyer proposed the metaplasia theory in 191942 which was further refined by 
Gruenwald43 into the coelomic metaplasia theory. This suggests that cells in the lining 
of the coelomic cavity are able to differentiate into endometrial tissue under the 
influence of certain factors.  Cases of endometriosis in which retrograde menstruation 
cannot occur, such as Rokitanshky-Kuster-Hauser syndrome support this theory44-46. 
Additionally it has been suggested that some types of deeply infiltrating disease are 
due to local metaplasia47 48. 
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2.4 Embryonic cells 
Distant site endometriosis cannot be explained by either of the above theories, and the 
theory of embryonic cell transformation has been proposed to explain this. Pluripotent 
embryonic stem cells may undergo differentiation into functioning endometrium at 
any site in the body. This may explain case reports of catamenial haemo- and 
pneumothorax49, catamenial nasal haemorrhage, brain and other distant site deposits. 
The alternative theory for these sites is the lymphatic / blood borne metastasis theory.  
 
2.5 Familial / genetic characteristics 
There appears to be a genetic basis for the development of endometriosis. In a study 
by Kennedy50 230 women with surgically confirmed endometriosis in 100 families 
were identified. The families consisted of 19 mother-daughter pairs, 1 set of cousins 
and 56 sister pairs. There were 5 families with 3 affected sisters, 1 family with 5 
affected sisters, and 18 families with ≥3 affected members in more than one 
generation. The study confirmed a familial tendency for endometriosis and supports 
the hypothesis that endometriosis has a genetic basis.  However the pattern of 
inheritance is not Mendelian and is more likely to represent a polygenic and /or 
multifactorial etiology.  
 
The 5–8% risk observed for first-degree relatives is more consistent with 
polygenic/multifactorial tendencies than with a single mutant gene (25 or 50%). 
Either one assumes that more than a single gene is involved or that multiple alleles 
exist at a single locus. One or more Mendelian forms could coexist but polygenic 
inheritance is obligatory if endometriosis is assumed to be a single entity. Additional 
support for polygenic inheritance is the increased severity in familial cases51,52. As 
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predicted, the greater the severity of a polygenic disorder, the greater the underlying 
genetic liability53. Thus, the higher the proportion of affected relatives, the greater the 
likelihood that the affected individual has severe endometriosis. 
 
The number of genes necessary to explain observed heritability is surprisingly small. 
This is illustrated by the following reasoning: If three genes exist, each with two 
alleles, there are 27 different classes (3n). If three alleles exist per locus and two loci 
exist, 36 genotypes (6n) would be possible. As the number of genotypic classes 
increases, a histograph showing the distribution of genotypes (phenotypes) in the 
population will more closely approximate a normal distribution. Thus, continuous 
variation can be approximated in the population by only a few genes.   
 
Various specific genes have been suggested as playing a role in the development of 
the disease including the 1031T/C polymorphism of the TNF-alpha gene54 and 
various polymorphisms of the N-acetyl transferase 2 (NAT 2) gene55.  
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Chapter 3. Biochemical markers for endometriosis  
 
3.1 CA125 
Many biochemical markers have been investigated for the evaluation of 
endometriosis.  The most widely researched marker is Cancer Antigen 125 (CA125), 
which is known to be raised in moderate to severe endometriosis. This was first 
discovered by Bast56 in 1981and is a mucin-type glycoprotein with a molecular 
weight of over 200,000 daltons57. It has two major binding domains A and B: these 
bind the monoclonal antibodies OC125 and M11 respectively58.  Apart from 
endometriosis, there are many other benign and malignant diseases, which can raise 
CA125 including uterine leiomyomas59,60, adenomyosis61 and pelvic inflammatory 
disease62 all of which can be associated with pelvic pain.   
 
A meta-analysis63 by Mol showed that CA125 is a better discriminator for stage 3 and 
4 disease than stage 1 and 2 disease.  In this study the test’s performance in 
diagnosing all disease stages was limited: the estimated sensitivity was only 28% for a 
specificity of 90% (corresponding likelihood ratio of a raised level is 2.8). The test’s 
performance for moderate–severe endometriosis was better: for a specificity of 89%, 
the sensitivity was 47% (corresponding likelihood ratio of a raised level is 4.3).  
However, most of the studies included in this meta-analysis used a CA125 cut off 
level of 35IU/ml. 
 
An interesting study by Kafali64 looked at 28 patients who were having laparoscopies 
for infertility.  CA125 levels in the menstrual phase of the cycle were compared with 
CA125 levels in the rest of the cycle.  They found that there was no difference in the 
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patients who did not have endometriosis but there was a large difference in patients 
who did have endometriosis.  Using a cut-off point of an 83% increase in CA125 
levels between the menstrual and the non-menstrual phase of the cycle gave a 
sensitivity of 93% and a specificity of 92% specificity.  All of the endometriosis 
found was either stage 1 or 2.   
 
Since then there have been studies to further investigate the role of CA125 in the 
diagnosis of deeply infiltrating endometriosis as separate from ovarian disease.  In a 
cohort study by Patrelli65 serum CA125 values were significantly elevated in patients 
with ovarian and mixed endometriosis lesions (median levels 48 U/mL), compared 
with those who had exclusively extraovarian foci (median levels 27 U/mL), however 
the location did not affect the subsequent fertility rate after two years of follow up.  
 
3.2 VEGF, TNF-alpha and CRP 
Xavier66 showed that serum VEGF is raised in the late secretory phase of the cycle in 
patients with endometriosis. Serum TNF-alpha concentrations were also raised 
throughout the cycle in women with endometriosis compared with controls66. A 
positive correlation between CRP and VEGF was also found throughout the menstrual 
cycle except for the early secretory phase. However there was no statistical difference 
in CRP between women with endometriosis compared with controls. Fasciani67 found 
that serum VEGF concentrations were significantly raised in patients with 
endometriomas and malignant ovarian disease when compared with other benign 
ovarian cysts. Conversely Gagne68 found no increase in serum VEGF level in 




IL-6 is a regulator of inflammation and immunity, which may play a role in linking 
the endocrine and the immune systems. It also modulates secretion of other cytokines, 
promotes T-cell activation and B-cell differentiation and inhibits growth of various 
human cell lines69.  IL-6 is produced by monocytes, macrophages, fibroblasts, 
endothelial cells, vascular smooth-muscle cells and endometrial epithelial stromal 
cells and by several endocrine glands, including the pituitary and the pancreas70.  In 
one study, it was found that IL-6 was significantly elevated in the serum of 
endometriosis patients but not in their peritoneal fluid as compared with patients with 
unexplained infertility and tubal ligation/reanastomosis70 
Darai71 found that IL-6 was raised in the serum of patients with endometriosis when 
compare with other benign ovarian cysts but was reduced when compared with 
malignant ovarian tumours. Serum TNF-alpha levels were equally raised with 
endometriomas and malignant disease when compared with other benign tumours. 
Pellicer  . found that IL- is raised in the serum and follicular fluid of patients 
undergoing IVF treatment compared with controls.  
 
No studies have tested these five serum markers (CA125, CRP, TNF-alpha, VEGF 
and IL-6) together in patients undergoing laparoscopy for chronic pelvic pain to 
evaluate if they are helpful at distinguishing those with and without endometriosis. In 
addition no studies have attempted to integrate these markers together with history 
and ultrasound characteristics into a model for the diagnosis of endometriosis.  
 
3.4 Combination of serum markers. 
A study by Mihalyi72 has shown that it is possible to exclude endometriosis on a 
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serum test. In this cohort study they tested for IL6 and 8, tumour necrosis factor-
alpha, high-sensitivity C-reactive protein (hsCRP), and cancer antigens CA125 and 
CA-19-9.  Using stepwise logistic regression, moderate–severe endometriosis was 
diagnosed with a sensitivity of 100% (specificity 84%) and minimal–mild 
endometriosis was detected with a sensitivity of 87% (specificity 71%) during the 
secretory phase. Using LSSVM analysis, minimal–mild endometriosis was diagnosed 
with a sensitivity of 94% (specificity 61%) during the secretory phase and with a 
sensitivity of 92% (specificity 63%) during the menstrual phase.  Their aim was to 
provide a test that would have a high sensitivity and moderate specificity therefore 
enabling women without endometriosis to avoid having an invasive laparoscopy 
unnecessarily.  However, before these tests can be used in a clinical setting they 




4.0  Chapter 4: Thesis hypotheses  
 
• The hypothesis is that transvaginal ultrasound performed as part of a routine 
work up for patients with chronic pelvic pain is an accurate and reproducible 
diagnostic technique for the exclusion and staging of pelvic endometriosis.  
This should facilitate the correct referral to a general gynaecologist for 
assessment if mild to moderate endometriosis is expected and to a specialist 
tertiary referral centre if severe disease is expected. 
• The inclusion of subjective features such as symptomatology and tenderness 
during the TVS examination can help improve the accuracy of the diagnosis of 
the presence and severity of  endometriosis. 
• Combining serum CA125 levels with TVS characteristics will provide better 
diagnostic accuracy, in terms of the presence and severity of endometriosis, 
than either test alone. 
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4.1 Thesis aims 
The aim of this thesis is to assess: 
• the sensitivity of ultrasound for the detection of endometriosis in a population 
of women with chronic pelvic pain when compared with laparoscopy. 
• the inter-observer variability in the diagnosis of endometriosis between two 
ultrasound operators. 
• the ability of transvaginal ultrasound performed by experienced operators to 
predict the severity of pelvic endometriosis. 
• if it is possible to predict the presence and severity of pelvic endometriosis 
from symptomatology and tenderness at TVS. 
• if the addition of symptomatology and tenderness at TVS can help in the 
diagnosis of pelvic endometriosis in patients who have false negative findings 
for pelvic endometriosis at transvaginal ultrasound examination, and in doing 
so establish which patients would benefit from laparoscopy in spite of a 
normal TVS result.  
• if combining serum CA125 levels with TVS characteristics will provide better  
diagnostic accuracy, in terms of the presence and severity of endometriosis, 
than either test alone. 
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Chapter 5:  General methods  
 
The methods which follow are applicable to all studies with specific details for each 
study being explained in those chapters. 
 
These were prospective, observational, multicentre studies, which were conducted at 
King’s College Hospital and at University College Hospital in London. These are 
major teaching hospitals and the latter included a specialist tertiary endometriosis 
centre. Consecutive women with clinically suspected or proven pelvic endometriosis 
were invited to join the study.  The inclusion criteria were: pre-menopausal women 
with a clinical suspicion of endometriosis awaiting diagnostic laparoscopy; women 
diagnosed with pelvic endometriosis at diagnostic laparoscopy awaiting operative 
treatment, age 16 or over, ability to provide informed consent. Women who could not 
undergo a transvaginal ultrasound scan and those who became pregnant whilst 
awaiting surgery were excluded from the study. 
 
The studies were ethically approved and an information leaflet was given to all 
eligible women before assessment. Informed consent was obtained from all patients 
who agreed to take part in the studies.  
 
Procedures 
All women were assessed by the attending clinicians who obtained a detailed history, 
which was recorded on a dedicated clinical database (ViewPoint, GE Healthcare, 
Fairfield, Connecticut, USA). Women were specifically asked about symptoms 
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associated with endometriosis such as dysmenorrhoea, chronic pelvic pain, 
dyspareunia, subfertility, dyschezia and cyclic rectal bleeding.   
 
Transvaginal ultrasound examination was performed by four ultrasound operators 
who were all gynaecologists with a high level of expertise in gynaecological 
ultrasonography.  The ultrasound operators were blinded to any previous surgical 
findings.  All patients were operated on by four different laparoscopic surgeons with a 
high level of expertise in laparoscopic surgery.  When moderate, severe or deeply 
invasive disease (DIE) was present a complete surgical exploration of the pelvis was 
performed, involving dissection of the pouch of Douglas when obliterated and 
resection of any DIE, especially of bowel or RVS, so as not to miss any disease.  The 
operating surgeons were blinded to the detailed transvaginal ultrasound findings. 
 
Transvaginal ultrasound assessment of pelvic endometriosis 
All women were examined in the dorsal lithotomy position using a high resolution 
transvaginal ultrasound probe.  The examinations were performed in a standardised 
and systematic way. Firstly the uterus was assessed in the transverse and sagittal 
planes. Next the ovaries were found and their size was measured in three orthogonal 
planes.  
 
Ovarian cysts were diagnosed as endometriomas when they appeared as well 
circumscribed thick walled cysts which contained homogenous low level internal 
echos (“ground glass”)73 (Figure 2).  Measurements were recorded from the inside of 
the cyst wall in three orthogonal planes.  The adnexa were also systematically 
examined for the presence of tubal dilatation.  
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Ovarian mobility was assessed by a combination of gentle pressure with the vaginal 
probe and abdominal pressure with the examiner’s free hand as in a bimanual 
examination.  The ovary was deemed to be completely free when all of its borders 
could be seen sliding across the surrounding structures.  Minimal adhesions were 
considered to be present when some of the surrounding structures could not be 
separated from the ovary with gentle pressure but the ovary could be mobilised from 
the majority (approximately >2/3) of the surrounding structures. Moderate adhesions 
were thought to be present when the ovarian mobility was reduced due to adhesions 
with the surrounding structures but the structures on 2/3-1/3 of the surface of the 
ovary were sliding across it on gentle pressure. Fixed ovaries could not be mobilised 
at all with gentle pressure nor separated from the surrounding structures (Figures 3 
and 4). If the tubes were dilated the mobility of the dilated tubes was documented in a 
similar fashion. Normal fallopian tubes are difficult to identify in the absence of 
background fluid in the pelvis and therefore it was not possible to score non dilated 
tubes for adhesions. It is difficult to see filmy adhesions on TVS unless there is fluid 
entrapped within the adhesions, giving rise to the “flapping sail sign”74, or unless the 
mobility of the affected organs is reduced and therefore these features were not scored 
separately at TVS. 
 
The presence of adhesions in the pouch of Douglas was assessed next.  The uterus 
was gently mobilised by a combination of pressure on the cervix with the ultrasound 
probe alternating with pressure on the fundus from the examiners free hand on the 
abdominal wall.  The aim was to watch the interface of the posterior uterine serosa 
and the bowel behind to ensure that the two structures were sliding easily across one 
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another.  If these two surfaces were completely free of one another this was assessed 
as no adhesions present. Complete obliteration was assessed as the absence of any 
sliding between the serosa on the posterior surface of the cervix or uterus and the 
bowel behind. Partial obliteration of the pouch of Douglas was present if there were 
some adhesions between the bowel and the uterus but some free sliding was seen.   
Partial obliteration was also present when adnexal structures were firmly adherent to 
the posterior aspect of the uterus but the bowel appeared to be free.  
 
Endometriotic nodules or deeply invasive endometriosis (DIE) were typically 
visualised as stellate hypoechoic or isoechogenic solid masses with irregular outer 
margins75 which were tender on palpation and fixed to the surrounding pelvic 
structures. They were usually located in the uterosacral ligaments, adnexa, 
rectovaginal septum, and urinary bladder (Figure 7).  Endometriotic nodules located 
in the wall of the rectosigmoid colon tend to appear as hypoechoic thickenings of 
bowel muscularis propria (Figures 5 and 6), which sometimes protrude into the lumen 
of the bowel76. The presence and largest diameter of any deep lesions were 
documented.  
 
All these findings were recorded on a database file using a Microsoft Excel for 
Windows spreadsheet to facilitate data entry and retrieval.  The severity of 
endometriosis as assessed by TVS was compared with laparoscopic findings using the 






All statistical analyses were carried out using Medcalc version 9.2.0.2 (Medcalc 
Software, Mariakerke, Belgium). The diagnostic accuracy of the tests was assessed 
using sensitivity, specificity, positive (PPV) and negative (NPV) predictive value, and 
positive (LR+) and negative (LR−) likelihood ratio measures. Overall levels of 
agreement for non binary data was calculated using Cohen’s quadratic weighted 
Kappa coefficient.  Kappa values of 0.81-1.0 indicated very good agreement, Kappa 
values of 0.61-0.80 good agreement, Kappa values of 0.41-0.60 moderate agreement, 
Kappa values of 0.21-0.40 fair agreement and Kappa values  <0.20 poor agreement77-
79.   The Kruskal-Wallis one-way analysis of variance was used to assess for statistical 
difference between rank sum of the groups as the data was not normally distributed.   
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Figure 2.  Transvaginal ultrasound image of an ovarian 














Figure 3. Transvaginal ultrasound image of an ovarian 






Figure 4. Transvaginal ultrasound image of ovarian endometriomas 
within each ovary causing adhesions between the ovaries and the 
posterior aspect of the uterus:  “The kissing ovaries” sign. 
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Figures 5 and 6. Two transvaginal ultrasound images of  hypoechoic 
thickening of the muscularis layer of the rectum due to deeply 





Figure 7. Transvaginal ultrasound image of deeply infiltrating 
endometriosis of the bladder. 
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Chapter 6: Study 1 
The reproducibility of the assessment of severity of 




As stated in the introduction (chapter 1.5) there is no clear consensus regarding the 
definition of severe endometriosis80,81 and the most commonly used classification, the 
American Society of Reproductive Medicine (ASRM) classification7 , has advantages 
and disadvantages.  The advantage of this classification is that it is widely used in 
clinical practice and provides a formalized systematic approach to documenting the 
impact of the disease on the patient’s fertility. However many authors recognize that 
the features of deeply infiltrating endometriosis (DIE) are often the most 
symptomatic2,82 and difficult to treat83.  These features are poorly represented in the 
ASRM classification and therefore need to be documented separately.    
 
In keeping with the recommendations of Khan84 any diagnostic test has to have the 
reliability (the test has to give a similar measurement when repeated by different 
observers) tested prior to the validity (the measurement must be accurate when 
compared with the “true” state of the attribute estimated by a suitable reference 
standard.  Therefore in this study we tested the inter-observer reproducibility of the 
diagnosis of both the individual features of endometriosis and the overall severity.  
No previous study has tested this before.  
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The aim of the study was to establish whether TVS is a reproducible technique for the 
preoperative assessment of the severity of pelvic endometriosis. 
 
Materials and Methods 
This was a prospective, observational, multicentre study, which was conducted at 
King’s College Hospital and at University College Hospital in London. These are 
major teaching hospitals and the latter included a specialist tertiary endometriosis 
centre.  Women with clinically suspected or proven pelvic endometriosis were invited 
to join the study.  The inclusion criteria were: pre-menopausal women with a clinical 
suspicion of endometriosis awaiting diagnostic laparoscopy; women diagnosed with 
pelvic endometriosis at diagnostic laparoscopy awaiting operative treatment; age 16 
or over; ability to provide informed consent. Women who could not undergo a 
transvaginal ultrasound scan and those who became pregnant whilst awaiting surgery 
were excluded from the study. 
The study was ethically approved and an information leaflet was given to all eligible 
women before assessment. Informed consent was obtained from all patients who 
agreed to take part in the study.  
 
Methods. 
All women were assessed separately by both attending clinicians who obtained a 
detailed history, which was recorded on a dedicated clinical database (ViewPoint, GE 
Healthcare, Fairfield, Connecticut, USA). Women were specifically asked about 
symptoms associated with endometriosis such as dysmenorrhoea, chronic pelvic pain, 
dyspareunia, subfertility, dyschezia and cyclic rectal bleeding.   
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Transvaginal ultrasound examination was performed by two ultrasound observers 
who were both gynecologists with a high level of expertise in gynecological 
ultrasonography.  All patients were examined by both ultrasound observers and the 
observers were blinded to each other’s findings.   The ultrasound observers were also 
blinded to any previous surgical findings.  All patients were operated on by two 
different laparoscopic surgeons with a high level of expertise.  When moderate, 
severe or deeply invasive disease (DIE) was present a complete surgical exploration 
of the pelvis was performed, involving dissection of the pouch of Douglas (when 
obliterated) and resection of any DIE, especially of bowel or RVS, so as not to miss 
any disease.  The operating surgeons were blinded to the detailed transvaginal 
ultrasound findings. 
 
Transvaginal ultrasound assessment of pelvic endometriosis was performed as 
described in the general method section (chapter 5).  
 
Statistical Analysis 
All statistical analyses were carried out using Medcalc version 9.2.0.2 (Medcalc 
Software, Mariakerke, Belgium).  In order to determine any systematic bias between 
the two diagnostic methods and to assess the relationship between any differences and 
the magnitude of the scores, the differences in score were plotted against the mean of 
the two scores on a scatter diagram. Systematic bias between the two observers was 
determined by calculating the 95% confidence interval of the mean (mean ± 2 
standard errors) as described by Bland and Altman77.   If 0 lay between this interval 
then no bias was assumed to exist. Cohen’s quadratic weighted Kappa coefficient was 
calculated to determine agreement between the two observers in classifying the stage 
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of the disease and also the presence of the individual features of the disease. Kappa 
values of 0.81-1.0 indicated very good agreement, Kappa values of 0.61-0.80 good 
agreement, Kappa values of 0.41-0.60 moderate agreement, Kappa values of 0.21-




In the three year period from August 2006 to July 2009 thirty four patients were 
recruited to the study and all had TVS examination performed by both ultrasound 
observers (A and B).  Of these patients one cancelled her laparoscopy and was 
therefore excluded from the final analysis. The mean age of the patients at recruitment 
was 33.8 years (range 18-51 years).   The presenting symptoms were: dysmenorrhoea 
(29/33, 87.9%), dysparunia (20/33, 60.6%), chronic pelvic pain (19/33, 57.5%), 
infertility (11/33) 33.3%), Dyschezia (11/33, 33.3%), cyclic rectal bleeding (1/33, 
3%).  Of these patients 12 (36.4%) had no endometriosis found, 1(3%) had minimal 
disease, 1 (3%) had mild disease, 5 (15.2%) had moderate disease and 14 (42.4%) had 
severe disease.  The mean interval between scan and laparoscopy was 35.2 days (95% 
CI 32.0–38.6; SD, 21.1). 
 
There was a good overall level of agreement between the ultrasound observers at 
identifying absent, minimal, mild, moderate and severe disease (quadratic weighted 
kappa = 0.931, standard error (Kw_ = 0) = 0.172, standard error (Kw_#0) = 0.034). 
The agreement between the TVS and laparoscopy findings for stage were also very 
good (kappa = 0.955, standard error (Kw=0) =0.174, (Kw_#0)=0.021 for observer A 
and Kappa = 0.966, standard error (Kw=0) =0.174, (Kw#0)=0.019 for observer B).  
The correlation coefficient for the ASRM scores was 0.987 (95 % CI 0.973-0.993) for 
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observers A and B, 0.963 (95 % CI 0.926-0.982) for observer A and laparoscopy and 
0.966 (95 % CI 0.932-0.983) for observer B and laparoscopy. When the ASRM score 
was compared using a scatter diagram of the differences in score between the two 
observers plotted against the mean score, (Figure 8) (after Bland and Altman) this 
showed the limits of agreement were -16.1 and 12.4.  The mean difference was -1.82 
(95% confidence interval for the mean = -4.35 to 0.71).  As the confidence interval 
for the mean difference contains zero no bias was assumed to exist. Visual inspection 
of scatter also revealed that the magnitude of differences between the scores recorded 
by each observer did not change with increasing score magnitude (Figures 9 and 10).  
 
Table 1 shows the inter-rater agreement between observers A and B, and between 




Figure 8. Bland Altman plot of difference between ASRM scores for 






































Figure 9. Bland Altman plot of difference between ASRM scores for 
ultrasound observer A and score at laparoscopy plotted against the 
average score for both. 
 
 































Figure 10. Bland Altman plot of difference between ASRM scores for 
ultrasound observer B and score at laparoscopy plotted against the 
average score for both. 
 






























Table 1 Inter-rater agreement between observers A and B, and 
between each of the observers and laparoscopy, for assessing the 
individual features of severe endometriosis. 
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Legend for table 1. DIE = deeply infiltrating endometriosis, POD = pouch of Douglas, 





Assessment of the reproducibility of a diagnostic test is an essential part of evaluating 
its accuracy. This is the first study to prospectively examine inter-observer variability 
of TVS for the assessment of pelvic endometriosis.   
 
Overall TVS performed well at assessing the stage of disease with very good levels of 
agreement between observers A and B, and between each of these observers and the 
stage found at laparoscopy.   There were also very high correlation coefficients for the 
ASRM score between observers A and B, and between these observers’ scores and 
the scores given to the findings at laparoscopy. 
 
When the detection rates of individual features of endometriosis were compared 
between the observers, there were very good levels of agreement regarding diagnosis 
of endometriosis of the bladder, ovarian adhesions and pouch of Douglas obliteration. 
The high level of agreement for the diagnosis of bladder endometriosis is concordant 
with previous studies, which showed a high level of accuracy in the TVS diagnosis of 
bladder endometriosis85,86. There was also a good level of agreement for the diagnosis 
of ovarian adhesions.  The preoperative diagnosis of ovarian adhesions has not been 
extensively investigated; however, Okara28 found a high level of accuracy with kappa 
= 0.80.  Prior to this in a study by Guerriero27 in 1997 a moderate level of accuracy 
was found (Kappa = 0.50).  The preoperative diagnosis of partial or complete 
obliteration of the pouch of Douglas has not been reported on directly before.  
Hudelist26 gave a high accuracy for the diagnosis of pouch of Douglas endometriosis 
but did not report obliteration separately. 
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There were moderate levels of agreement between observers A and B regarding 
endometriosis of the bowel and rectovaginal septum.  There were high levels of 
agreement between observer B and laparoscopy for both these features. However, 
observer A did not perform as well for these features and this is likely to be the cause 
of reduced level of agreement between A and B. Previous studies have also shown 
lower sensitivity for the diagnosis of endometriosis in these area26,86.    
 
There were fair to poor levels of agreement for endometriosis affecting the uterosacral 
ligaments and pelvic side walls.  This could be explained by the low prevalence of 
endometriosis in these areas in the study population. Low accuracy of TVS for 
diagnosing endometriosis of the uterosacral ligaments and pelvic side walls has also 
been previously reported83,86 . The diagnosis of endometriosis in these locations is not 
critical for the management as surgical excision can usually be achieved without 
involvement of other surgical specialists.    
 
Although there are no studies assessing the reproducibility of TVS in the diagnosis of 
endometriosis, previous studies have examined the inter-observer variability of 
laparoscopy for the diagnosis of endometriosis.  Interestingly, although laparoscopy is 
currently the gold standard test, previous studies have shown significant intra- and 
inter-observer variability.  
 
Hornstein87 asked 5 specialists to view video recordings of laparoscopies of patients 
with endometriosis and score according to the ASRM classification.  Each video was 
viewed twice in order to assess intra- observer variability.  The greatest variability 
occurred in endometriosis of the ovary and cul-de-sac obliteration, with less 
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variability observed for peritoneum endometriosis and for ovarian and tubal 
adhesions. Buchweitz88 in 2005 asked one hundred and eight gynecologic surgeons to 
view three videos of laparoscopies.  The patients had stage one disease, stage two 
disease and no disease. The surgeons were asked to indicate the endometriotic lesions 
on a prepared surgical sketch and to classify the site according to the ASRM 
classification.  They found a correct classification of the endometriotic disease stages 
I and II in only 22% and 13% of the cases, respectively and concluded that the visual 
assessment of a videoed laparoscopy with minimal and mild endometriosis is subject 
to considerable intra and inter-observer variability.    
 
Weijenborg89 in 2007 asked two observers to review 90 videos of laparoscopies and 
found a high level of agreement in the stage of the disease but fair to moderate level 
of agreement of regarding the presence or absence of adhesions in the intra- and inter-
observer setting, respectively.  
 
In our study, we were not able to assess intra-observer reproducibility as all the 
patients were examined real time and it was not felt to be appropriate to subject 
patients to additional repeated examinations solely for the purpose of this study.  
Further research in to the intra-observer variability of TVS in endometriosis diagnosis 
would be valuable.  
 
We have included data regarding agreement between observers A and B and 
laparoscopy findings for stage, ARSM score and individual features in order to 
explain some of the variation in inter-observer agreement. The data shows high levels 
of agreement for A and B with respect to laparoscopy findings for the stage of disease 
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and the ASRM score. However, when there was poorer diagnostic accuracy for a 
specific feature of disease, the inter-observer agreement also worsened.  
 
Conclusion  
Although laparoscopy remains the gold standard for the diagnosis of endometriosis, 
our results confirm that TVS is a suitable and reproducible method for the initial 
assessment of patients with suspected endometriosis and it may be used to 
appropriately triage patients with severe disease to local specialists or tertiary 
endometriosis centres. 
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Chapter 7.  Study 2 
Ultrasound mapping of pelvic endometriosis: does the 




The aim of this study is to assess the accuracy of pre-operative transvaginal 
ultrasound scanning (TVS) in identifying the specific features of pelvic endometriosis 
and pelvic adhesions in a population of women with chronic pelvic pain when 








All statistical analyses were carried out using Medcalc version 9.2.0.2 (Medcalc 
Software, Mariakerke, Belgium). The diagnostic accuracy of the tests was assessed 
using sensitivity, specificity, positive (PPV) and negative (NPV) predictive value, and 
positive (LR+) and negative (LR−) likelihood ratio measures. Area under the receiver 
operator curves were calculated for the overall accuracy.  
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Results. 
From July 2006 to September 2009 we recruited 237 women into this study. 39 
women were excluded from the final analysis: twenty nine because they were not 
assessed by one of the two designated ultrasound operators, five became pregnant 
whilst awaiting surgery, one cancelled her operation, one laparoscopy was 
unsuccessful and three women were lost to follow up.  
 
198 women were included in the final analysis. The mean age was 35.0 (95% CI 
33.98 – 35.97, SD 7.10) (range 19-50) years. The presenting symptoms were 
dysmenorrhoea for 143/198 (72.2%), chronic pelvic pain for 98/198 (49.5%), 
dyspareunia for 91/198 (45.9%), infertility for 42/198 (21.2%), dyschezia for 19/198 
(9.6%) and cyclic rectal bleeding for 3/198 (1.5%) women.  A single presenting 
symptom was present in 72/198 (36.4%) women, two presenting symptoms in 66/198  
(33.3%), three presenting symptoms in 39/198 (19.7%), four or more symptoms in 
19/198 (9.6%) women.  
 
At laparoscopy 126 /198 (63.6%) women had endometriosis. Of these women 30 /126 
(23.8%) had stage 1 endometriosis by the rASRM classification, 24/126 (19.0%) had 
stage 2, 21/126 (16.7%) had stage 3 and 51/126 (40%) had stage 4 disease.  Of the 
104 women with focal lesions (excluding women with only diffuse superficial 
peritoneal disease) 28/104 (26.9%) women had endometriosis in a single location 
whilst the remaining 73.1% had endometriosis in two or more locations. 
 
The ultrasound examinations were performed by two examiners: examiner A 
performed 104 (52.5%), examiner B 94 (47.5%).  All patients were operated on by 
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one of four laparoscopic surgeons: surgeon A operated on 79 (39.9%), surgeon B on 
54 (27.3%), surgeon C on 35 (17.7%) and surgeon D on 30 (15.2%) women. The 
mean interval between TVS and operation was 36.8 days (95% CI 33.4 – 41.1, SD 
22.9) (range 0-87 days).  
Table 2 shows the prevalence of the individual features of pelvic endometriosis at 
laparoscopy. Table 3 gives the details of the individual locations of endometriosis in 
relation to whether they were isolated lesions or multifocal lesions. Of the 104 women 
with focal lesions (excluding women with only diffuse superficial peritoneal disease) 
28/104 (26.9%) of these women had endometriosis in a single location whilst the 
remaining 73.1% had endometriosis in two or more locations. 
Ovarian endometriomas were rarely isolated lesions as ovarian adhesions were also 
present in 48/51 (94%) of cases. 27/51 (52.9%) women with endometriomas had 
unilateral and 24/51 (47.1%) had bilateral lesions.  There was no significant 
difference in the frequency of endometriomas located in the right or left ovary (Chi-
square =0.327 p=0.51).  Women with bilateral endometriomas were no more likely to 
have associated DIE 16/24 (66.6%) compared to women with unilateral 
endometriomas 14/27 (51.8%) (Chi-square =0.621 p=0.431 stat).  
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Table 2. The prevalence of endometriotic lesions at different 
anatomical locations at laparoscopy 
 
Site of disease  N (%) 












DIE of USL unilateral  
DIE of USL bilateral 
8/198 (4.0%) 
12/198 (6.1%) 
Complete obilteration of POD 
Partial obilteration of POD 
30/198 (15.2%) 
24/198 (12.1%) 
DIE of Rectum / Sigmoid 11/198 (5.6 %) 
DIE of RVS 32/198 (16.2%) 
DIE of bladder 5/198 (2.5%) 
DIE of utero vesical fold (separate from bladder) 6/198 (3.0%) 
DIE of PSW unilateral 




DIE is deeply infiltrating endometriosis, USL is uterosacral ligaments, POD is pouch 
of Douglas, RVS is rectovaginal septum, PSW is pelvic side wall.  
 
 
Table 3 Isolated and multiple endometriotic lesions in respect to their 
locations.  








Ovarian  endometrioma n=51 2/51   (3.9%) 49/51   (96.1%) 
Ovarian adhesions n= 85 16/85   (18.8%) 69/85   (81.2%) 
Adhesions in POD n=54 1/54   (1.9%) 53/54   (98.1%) 
USL DIE n= 23 5/23   (21.7%) 18/23   (88.3%) 
RV or POD DIE n= 32 1/32   (3.1%) 31/32   (96.9%) 
DIE of rectum or sigmoid n=9 0/9   (0%) 9/9   (100%) 
DIE of bladder n=5  1/5   (20%) 4/5   (80%) 
DIE of UVF n=6 1/6  (16.7%) 5/6   (83.3%) 
DIE of PSW n=9 1/9  (11.1%) 8/9   (88.9%) 
Total 28/104 (26.9%) 76/104 (73.1%) 
 
DIE is deeply infiltrating endometriosis, USL is uterosacral ligaments, POD is pouch 
of Douglas, RVS is rectovaginal septum, UVF is utero vesical fold, PSW is pelvic 





Diagnostic accuracy of pre-operative TVS for each of the specific anatomical 
locations of endometriosis is shown in Table 4.  There was a significant difference 
between the sensitivities for the different locations (Chi squared= 74.97, P<0.0001) 
while the specificities were similar (p>0.05).  The positive likelihood ratio (LR+) was 
very useful (>10) for the TVS diagnosis of endometriosis of the following anatomical 
locations: ovarian endometriomas; moderate or severe ovarian adhesions; pouch of 
Douglas adhesions; and deeply infiltrating endometriosis (DIE) of the bladder; rectum 
or sigmoid; rectovaginum; uterovesical fold; and the uterosacral ligaments.  Only for 
pelvic side wall DIE and mild ovarian adhesions was the LR+ moderately useful (5-
10).  The negative likelihood ratio (LR-) was very useful (<0.1) for bladder DIE and 
moderately useful (0.1-0.2) for ovarian endometriomas, moderate or severe ovarian 
adhesions, and pouch of Douglas adhesions.  The sensitivity was highest for bladder 
and ovarian endometriomas and lowest for DIE of the uterovasical fold, pelvic side 
wall and uterosacral ligaments.   
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Table 4 Accuracy of pre-operative ultrasound diagnosis of 
endometriotic lesions affecting different pelvic organs. 
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  (95% 
CI 0.424-
1.07) 
0.661 (95% CI 
0.591 – 0.727)  
P= 0.111 
RV DIE  
N= 32 
50.0 (95% 
CI 33.6 – 
66.4) 
100 (95% 
CI 97.7 – 
100) 
100 










CI 0- ∞) 
0.50 
  (95% 
CI 0.354-
0.707) 
0.758 (95% CI 
0.692– 0.816)  
P = 0.0001 
DIE of UVF 
N=6 
16.7 (95% 
CI 2.8 – 
63.9) 
99.0 (95% 
CI 96.3 – 
99.8) 
33.3 
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CI 0.589- 
1.205) 
0.578 (95% CI 
0.506 – 0.648)  
P = 0.528 
DIE of PSW 
N=13  
15.4 (95% 
























0.568 (95% CI 
0.517 – 0.617)  
P = 0.419 
DIE of USL  
N=40 
10.0 (95% 
CI 2.9 – 
23.7) 
99.16(95% 
CI 97.6 – 
99.8) 
57.1 














  (95% 
CI 0.818- 
1.007) 
0.546 (95% CI 
0.495 – 0.596)  
P = 0.351 
 
PPV is positive predictive value, NPV is negative predictive value, +ve LH is positive 
likelihood ratio, -ve LH is negative likelihood ratio, ROC is receiver operating 
characteristics, DIE is deeply infiltrating endometriosis, RV is rectovaginal, UVF is 
utero vesical fold (separate from bladder), PSW is pelvic side wall, USL is uterosacral 





The LR+ and –LR for all adhesions on the ovaries were moderately and somewhat 
useful respectively. However for the assessment of moderate or severe adhesions on 
the ovary the LR+ and –LR was very and moderately useful respectively as detailed 
in table 4.  When the diagnosis of ovarian adhesions was stratified according to the 
ASRM classification into mild, moderate and severe the overall level of agreement 
between scan and laparoscopy was very good  (Table 6). The LR+ and –LR for 
adhesions in the pouch of Douglas were very and moderately useful respectively as 
detailed in table 5.  When pouch of Douglas obliteration was assessed according to 
the ASRM classification into partial and complete obliteration the overall level of 
agreement between scan and laparoscopy was very good (Table 7). Table 8 shows 
that the accuracy of the diagnosis of DIE increases significantly with the total number 
of endometriotic lesions present.  This data is represented graphically in figure 11. 
Table 8 shows that although the number of endometriotic lesions seen on scan 
significantly increases with the number of lesions present (fig 12) the proportion of 
the total lesions correctly diagnosed increases to a maximum at three lesions present 
at laparoscopy then declines (fig 13).   
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Table 5 Accuracy of pre-operative ultrasound diagnosis of pelvic 
adhesions in women with suspected endometriosis. 
Site of 
disease 
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POD N= 54 
83.3 (95% 
CI 71.3- 
























0.892 (95% CI 0.841- 
0.932)  

































0.902 (95% CI 0.852- 
0.939) 
P = 0.0001 
 
 
PPV is positive predictive value, NPV is negative predictive value, +ve LH is positive 
likelihood ratio, -ve LH is negative likelihood ratio, ROC is receiver operating 
characteristics, POD is pouch of Douglas.
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Table 6 Comparison of ultrasound and laparoscopy for the 
assessment of severity of ovarian adhesions.  
 





Absent Minimal Moderate Severe Total 
Absent 238 6 5 10 259 (65.4%) 
Minimal 10 3 0 1 14 (3.5%) 
Moderate 7 1 4 8 20 (5.1%) 
















Table 7 Comparison of ultrasound and laparoscopy for the 
assessment of severity of adhesions in the pouch of Douglas.  
 










No adhesions 137 4 3 144 (72.7%) 
Partial 
obliteration 
9 13 2 24 (12.1%) 
Complete 
obliteration 
0 5 25 30 (15.2%) 
Total 146 (73.7%) 22 (11.1%) 30 (15.2%) 198 
 




Table 8.   Women with DIE separated into groups by total number of 
endometriotic lesions compared with the accuracy of diagnosis of 
DIE in each group.  
 
Total number of 
endometriotic lesions  
Number of women (n=61) Number correctly 
diagnosed with DIE (n, %) 
Single lesions  10 1 (10.0%) 
2 lesions 8 3 (37.5%) 
3 lesions  16 9 (56.3%) 
4 lesions 16 11 (68.8%) 
5 lesions or more 11 8 (72.7%) 
 
Kruskal-Wallis test of correlation between total number of lesions and % of women 
correctly identified with DIE (P = 0.0228). 
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Figure 11.  Bar chart of total number of endometriotic lesions at 
laparoscopy against percentage of women correctly diagnosed with 
DIE in each group.   





































Table 9 shows the mean number and mean proportion of lesions 
diagnosed on scan for all women with endometriotic lesions grouped 
by total number of lesions.  
Total number of lesions Number of women 
N=104 
Mean number of 
lesions diagnosed on 
scan 
Mean proportion of 
total lesions diagnosed 
on scan 
Single lesions  28 0.429 (95% CI 0.207 
to 0.651) 
 0.3929 (95% CI 
0.2000 to 0.5857) 
2 lesions 25 1.800 (95% CI 
1.4232 to 2.1768) 
0.8000 (95% CI 
0.6541 to 0.9459) 
3 lesions  24 2.8750 (95% CI 
2.4562 to 3.2938) 
0.8750 (95% CI 
0.7749 to 0.9751) 
4 lesions 16 3.5625 (95% CI 
3.0871 to 4.0379) 
0.8594 (95% CI 
0.7756 to 0.9432) 
5 lesions or more 11 3.5455 (95% CI 
2.4471 to 4.6438)  
0.6450 (95% CI 
0.4584 to 0.8316) 
  P< 0.0001* P= 0.0008* 
 
*Kruskal-Wallis test of correlation between total number of lesions at laparoscopy 
and mean number of lesions diagnosed on scan and mean proportion of total lesions 
diagnosed on scan respectively.  
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Figure 12 Bar chart of total number of endometriotic lesions at 
laparoscopy against the mean number of lesions seen on scan in each 
group.  



































Figure 13 Bar chart of total number of endometriotic lesions seen at 
laparoscopy against mean proportion of lesions diagnosed on scan in 
each group.   



































Our study has shown that it is possible, using transvaginal ultrasound scanning, to 
predict features of pelvic endometriosis with a consistently high specificity and a high 
level of sensitivity for the most difficult to treat features eg RVS, bowel and bladder 
disease. The total number of endometriotic lesions found at laparoscopy has 
statistically significant positive effect on the accuracy of ultrasound diagnosis of 
deeply infiltrating lesions. The sensitivity of the ultrasound diagnosis was 
significantly affected by the location of the endometriotic lesions but the specificity 
remained high throughout.  We have shown for the first time that ultrasound enables 
detection and assessment of severity of adhesions affecting the ovaries and pouch of 
Douglas. 
 
A high accuracy for the diagnosis of the features of pelvic endometriosis is helpful for 
the management of these patients as they can be counselled regarding the most 
appropriate treatment modality.   If surgery is decided upon these patients can be 
directed to the most appropriate surgeon for their needs, which may mean being 
referred to a tertiary centre in patients who have bladder/ bowel DIE or an obliterated 
pouch of Douglas.  When these patients and their clinicians have decided that they 
would like to proceed with operative treatment an accurate diagnosis of the extent of 
the disease will enable a full discussion of the risks and benefits and therefore enable 
informed consent.  It will also aid the surgeon in planning the operation and ensuring 
that the necessary staff are present such as colorectal surgeons for bowel disease. 
Preoperative underestimation of the severity of DIE lesions is the reason why 
complete surgical exision may not be achieved resulting in progression of the 
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remaining disease90. For patients suffering from infertility it may aid in counselling 
them on the likely cause of infertility and consequences of pursuing a surgical 
approach to their management.  
 
Our study has shown a high accuracy in the diagnosis of ovarian adhesions, pouch of 
Douglas obliteration and bladder lesions.  The accuracy for these features was similar 
to the accuracy for ovarian endometriomas which were previously thought of as the 
only feature of pelvic endometriosis which it is possible to diagnose on TVS16. 
Previous studies have stated that left sided endometriomas are more common than 
right817 but there was no statistically significant difference in our data set.  Our study 
has also shown that only 26.9% of patients with focal endometriosis will have disease 
in only one location and therefore in all cases the examiner should perform a detailed 
search for lesions in other typical locations. 
 
There are few studies on the accuracy of TVS for the diagnosis of ovarian adhesions.  
Our study has shown a high level of accuracy for this diagnosis with a kappa value of 
0.798.  No study has previously assessed mobility as either minimal, moderate or 
severe adhesions for the ovary in accordance with the ASRM classification7.  
Guerriero27 used the combination of 3 features as suggestive of ovarian adhesions: 
blurring of the ovarian margin, the inability to mobilise the ovary on palpation 
(fixation) and an increased distance from the probe.  They found that these tests either 
combined or individually gave a kappa value of between 0.25 and 0.51.  Okaro28 
examined women with chronic pelvic pain prior to laparoscopy for the presence of 
ovarian adhesions and classified them as either mobile or fixed.  They found a high 
degree of agreement between TVS and laparoscopy at identifying ovarian adhesions 
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(0.81 kappa).  This compares with the results of our study of an area under the ROC 
of 0.883 for the presence of either moderate or severe adhesions and a kappa of 0.798 
for the three stages of severity.  Yazbek29 examined the role of ultrasound for the 
preoperative assessment of adnexal masses.  They found a sensitivity of 44% and a 
specificity of 98% in the diagnosis of severe pelvic adhesions.  The technique for 
examination of adhesions was similar to that used in this paper but they do not state 
ovarian adhesions separately.  Guerriero30 used a technique of applying pressure 
between the uterus and ovary. If they remained linked then this was suggestive of 
adhesions. This gave a sensitivity and specificity of 89% and 90% respectively for 
fixation of the ovaries to the uterus. 
 
The preoperative diagnosis of partial or complete obliteration of the pouch of Douglas 
has not been reported on directly before.  Our study shows a high accuracy of this 
diagnosis.  Hudelist91 gave a high accuracy for the diagnosis of pouch of Douglas 
endometriosis but did not report obliteration separately.  Yazbek29 described the 
technique for diagnosing POD obliteration but did not report this finding separately 
from severe pelvic adhesions.  
 
The high level of accuracy for the diagnosis of bladder endometriosis is concordant 
with previous studies, which showed a high level of accuracy in the TVS diagnosis of 
bladder endometriosis23,85,92. 
  
There were poor levels of sensitivity for the diagnosis of endometriosis affecting the 
uterosacral ligaments and pelvic side walls. The low accuracy of TVS for diagnosing 
endometriosis of the uterosacral ligaments and pelvic side walls has also been 
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previously reported83,86.  Hudelist26 reports higher levels of sensitivity for the 
diagnosis of uterosacral disease however these levels were lower than for almost all of 
the other locations of DIE.  The preoperative diagnosis of endometriosis in these 
locations is not critical for the management as these are rarely missed at laparoscopy 
and surgical excision can usually be achieved without involvement of other surgical 
specialists. 
 
Our study showed a high specificity of the diagnosis of rectovaginal septum disease 
and a lower sensitivity. This agrees with the results of a recent review by Hudelist93 
encompassing 10 studies on the diagnostic accuracy of TVS for intestinal 
endometriosis. He found sensitivities ranging from 67- 98% and specificities of 92-
100%.   
 
Hudelist26 compared pelvic examination alone with pelvic examination combined 
with TVS for the preoperative assessment of patients with suspected pelvic 
endometriosis. They found that by combining these two procedures it is possible to 
get sensitivities of 67- 100% for the diagnosis of features similar to our own.  They 
maintained high specificities with these findings of 86-100%.  It is likely that our pick 
up rate would be improved by the inclusion of a thorough pelvic examination prior to 
TVS.   
 
The effect of the number of lesions on the sensitivity of ultrasound diagnosis of 
specific endometriotic lesions in different locations has not been assessed before.  Our 
data shows that the accuracy of the diagnosis of individual specific lesions increases 
with their absolute number up to a maximum of three lesions. With increasing number 
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of lesions above that level the sensitivity declines.  A possible reason for this could be 
that in more severe disease the adhesions tend to obscure other small lesions further 
away from the ultrasound probe.  There is also a possibility of operator bias as in 
women with evidence of severe disease documentation of the presence of small 
lesions such as those located at utero-sacral ligaments becomes less clinically 
relevant.  
 
Our study could be criticised for not more accurately differentiating between DIE of 
the rectum, sigmoid, RVS and vagina.   We could also be criticised for including 
subjective assessments such as ovarian and pouch of Douglas mobility which can not 
be recorded with ease.  However our diagnostic accuracy of diagnosing ovarian and 
pouch of Douglas disease was higher than for other features and therefore is unlikely 
to be biased due to its subject nature.  It remains to be seen in further studies whether 
these subjective features are as reproducible as the more objective features.  Our study 
can also be criticised as both examiners were gynaecologists with a special interest in 
TVS.  As most of the TVS performed in the UK is by sonographers who have less 
experience of pelvic anatomy and pathology the findings may not be applicable to 
most units.   
 
Conclusions 
Our study has shown that the specificity of the ultrasound diagnosis of pelvic 
endometriotic lesions is high with low false positive rates.  The negative diagnostic 
rate was less high especially in the diagnosis of bowel, rectovaginal, uterosacral 
ligament, pelvic side wall and uterosacral ligament lesions.  Therefore women with 
significant symptoms and a negative diagnosis still require further investigation.  
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Chapter 8 Study 3 
The prediction of the severity of endometriosis by 
transvaginal ultrasound examination compared with 
findings at laparoscopy. 
 
Aim 
The aim of this study was to assess the ability of transvaginal ultrasound performed 
by experienced operators to predict the severity of pelvic endometriosis. 
 
Methods  
The methods for this study were the same as detailed in the general methods section 
above. 
 
Statistical analysis and sample size power calculation  
As no previous studies have been conducted to assess the accuracy of expert 
ultrasound scanning in the assessment of severity of endometriosis there are no 
figures on which to base a power calculation. In clinical practice it would be ideal to 
identify all cases of endometriosis.  Our hypothesis was that it would be clinically 
acceptable if transvaginal ultrasound had a sensitivity of 90% in identifying severe 
pelvic endometriosis. This study was designed to have 90% power to detect a 10 % 
difference between the sensitivity of diagnostic laparoscopy and transvaginal 
ultrasonography in detecting severe pelvic endometriosis with a two-sided α of 0.05. 
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The study needed a minimum of 190 patients, but we recruited 211 patients to allow 
for loss of power due to cancellations or pregnancy.   
 
All statistical analyses were carried out using Medcalc version 9.2.0.2 (Medcalc 
Software, Mariakerke, Belgium). The diagnostic accuracy of the tests was assessed 
using sensitivity, specificity, and positive (LR+) and negative (LR−) likelihood ratio 
measures.  Correlation was calculated using the coefficient of correlation R. In order 
to determine any systematic bias between the two diagnostic methods and to assess 
the relationship between any differences and the magnitude of the scores, the 
differences in score were plotted against the mean of the two scores on a scatter 
diagram (Figure 15). Systematic bias between the two observers was determined by 
calculating the 95% confidence interval of the mean (mean ± 1.96 standard 
deviations) as described by Bland and Altman77,78  Overall levels of agreement was 
calculated using Cohen’s quadratic weighted Kappa coefficient.  Kappa values of 
0.81-1.0 indicated very good agreement, Kappa values of 0.61-0.80 good agreement, 
Kappa values of 0.41-0.60 moderate agreement, Kappa values of 0.21-0.40 fair 




In the period of 30 months from July 2006 to December 2008 we recruited 211 
women into this study. 10 women were excluded from the final analysis: five became 
pregnant whilst awaiting surgery, one cancelled her operation, one laparoscopy was 
unsuccessful and three women were lost to follow up.  
 
201 women were included in the final analysis. The mean age was 34.9 (95% CI 
33.98 – 35.86, SD 6.79) (range 19-51) years. The presenting symptoms were 
dysmenorrhoea for 142/201 (70.6%), chronic pelvic pain for 104/201 (51.7%), 
dyspareunia for 78/201 (38.8%), infertility for 38/201 (18.9%), dyschezia for 7/201 
(3.5%) and cyclic rectal bleeding for 2 (1%) women.  A single presenting symptom 
was present in 72 (35.6%) women, two presenting symptoms in 78 (38.8%) and three 
or more symptoms in 51 (25.4%) women.  
 
The ultrasound examinations were performed by four examiners: examiner A 
performed 104 (51.7%), examiner B 68 (33.8%), examiner C 18 (9%) and D 11 
(5.5%) examinations. All patients were operated on by one of four laparoscopic 
surgeons: surgeon A operated on 70 (34.8%), surgeon B on 52 (25.9%), surgeon C on 
45 (22.3%) and surgeon D on 34 (16.9%) women. The mean interval between TVS 
and operation was 37.5 days (95% CI 34.3 – 40.8, SD 23.2) (range 0-87 days).   
 
Table 10 shows the findings on ultrasound compared with laparoscopy.  There was a 
good level of agreement between ultrasound and laparoscopy in identifying absent, 
minimal, mild, moderate and severe disease (Quadratic Weighted Kappa = 0.786, 
Standard error (Kw'=0) = 0.068, Standard error (Kw'#0) = 0.033).  
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Table 10. A comparison of ultrasound and laparoscopic assessment 
of the severity of pelvic endometrisois using rAFS classification. 
  Laparoscopy  
Ultrasound Absent Minimal Mild Moderate Severe Total (%) 
Absent 59 29 27 3 2 120 (59.7) 
Minimal 0 1 0 0 0 1 ( 0.5) 
Mild 1 1 4 2 1 9 ( 4.5) 
Moderate 2 1 0 20 4 27 (13.4) 
Severe 0 1 0 2 41 44 (21.9) 










Table 11. Diagnostic accuracy of ultrasound in diagnosing different 
stages of pelvic endometriosis using laparoscopy as the gold 
standard. 
 Sensitivity Specificity LR +ve LR -ve 
Absent vs Present 81/142 
(57.04%, 95% CI  
0.485 – 0.652) 
59/62 
(95.2%, 95% CI 
0.856- 0.987) 
11.78 
(95% CI 3.87 – 
35.88) 
0.45 
(95% CI 0.373 – 
0.546) 
Absent to mild vs 
moderate to severe 
67/ 75 
(89.0 %,  95% CI 
0.795 – 0.949) 
122/ 126 
(96.8%,  95% CI 
0.916- 0.989) 
28.14 
(95% CI 10.69 – 
74.0 ) 
0.11 
(95% CI 0.057 – 
0.212 ) 
Absent to moderate 
vs Severe 
41/48 
(85.4%,  95% CI  
0.716– 0.934) 
150/ 153 
(98.0%,  95% CI 
0.939- 0.994) 
43.5 
(95%CI  14.12 – 
134.38 ) 
0.149 
(95%CI  0.0749 – 
0.295) 
 
LR +ve = positive likelihood ratio,  LR –ve = negative likelihood ratio 
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Table 12. A comparison of inter-observer reproducibility of 
ultrasound diagnosis of severe pelvic endometriosis using 
laparoscopy as the gold standard.  
 
Examiner A B 
Sensitivity (%) 9/11 (81.8,  95% CI 47.7-96.8) 28/30 (93.0, 95% CI 783.71- 
987.25) 
Specificity (%) 92/93 (98.9, 95% CI 93.3-99.9) 37/38 (97.4, 95% CI 864.52- 
99.59) 
False positive rate 
(%) 
0.96 (1/104) (95% CI 0.17-5.3) 1.5 (1/68) (95% CI 0.26-7.9) 
False negative rate 
(%)  
1.9 (2/104) (95% CI 0.53-6.7) 0.96 (2/68) (95% CI 0.81-10.1) 
LR +ve 76.1 ( 95% CI 10.6- 545) 33.4 ( 95% CI 4.82 – 231) 
LR –ve 
 
0.184 ( 95% CI 0.0524 – 
0.644) 
0.099 ( 95% CI 0.0339- 0.292) 
PPV (%) 89.8 96.6 
NPV (%) 97.8 94.9 
Accuracy (Area 




*comparison of area under ROC curves P=0.627 
LR +ve = positive likelihood ratio,  LR –ve = negative likelihood ratio,  PPV = 




Sensitivity, specificity, positive and negative likelihood ratios of transvaginal 
ultrasonography in diagnosing pelvic endometriosis are shown in Table 11.  Table 12 
shows the accuracy of examiners A and B for detecting severe pelvic endometriosis.  
There was no significant difference found in overall accuracy between these two 
examiners when the area under the ROC curve was compared.  The numbers 
examined by C and D were not sufficient to make individual comparisons of accuracy 
meaningful and therefore the results of these examiners were not presented in Table 
12. 
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Deeply invasive endometriosis (DIE) is given a maximum score of six on the rAFS 
classification and therefore it is helpful to record the presence of these lesions 
separately.  Table 13 shows the presence of DIE in relation to severity as classified by 
rAFS.  The 17 cases of mild disease where DIE was present included the uterosacral 
ligaments in 12 (70.6 % 95% CI 46.8- 86.7), pelvic side wall in 4 (23.5% 95% CI 9.6- 
47.3), uterovesical fold/ bladder in 2 (11.8% 95% CI 3.3-34.3), pararectal space in 1 
(5.9% 95% CI 1.1-27.0), rectovaginal septum in 1 (5.9% 95% CI 1.1-27.0) and 
rectum in 1 (5.9% 95% CI 1.1-27.0). 13 (76.5% 95% CI 52.7- 90.4) cases had one site 
of DIE and the other 4 (23.5% 95% CI 9.6- 47.3) had two sites. Only one case, 
involving the bladder, was correctly diagnosed as having DIE on TVS. Table 4 shows 
the prevalence of DIE, and TVS sensitivity for DIE, in relation to severity classified 
by rAFS.  
 
 
Table 13. The prevalence of DIE and TVS sensitivity for DIE in 





None Minimal Mild Moderate Severe 
Total cases 62 33 31 27 48 
DIE present 
prevalence 
(%, 95% CI) 
0  
(0, 0- 5.8) 
0 











(%, 95% CI) 
N/A N/A 1/17 (5.9, 
1.1- 27.0) 
6/17 (35.3,  
17.3- 58.7) 
18/37 (48.7, 





Table 14 shows the sensitivity, specificity, positive and negative likelihood ratios and 
areas under the ROC curves for the diagnosis of: DIE involving the bladder and 
uterovesical fold; DIE of the rectovaginal septum and bowel; and complete 
obliteration of the pouch of Douglas. 
 
 
Table 14. Diagnostic accuracy of TVS in the assessment of features of 
severe endometriosis not clearly scored by rAFS. These features are: 
deeply invasive endometriosis of the bladder or utero-vesical fold; 
deeply invasive endometriosis of the rectovaginal septum, rectum or 
sigmoid colon; obliterated pouch of Douglas. 
 











Any of these 
featuresCombined  
features 




95% CI 27.3- 
64.0) 
18/25 (72.00 
95% CI 50.6 – 
87.9) 
23/38 (60.53 95% 
CI 43.4 – 75.9) 
Specificity % 192/192 (100  
95% CI 98.1 – 
100) 
170/170 (100 
95% CI 97.8 – 
100) 
171/176 (97.16 
95% CI 93.4 – 
99.0) 
156/163 (95.71 
95% CI 91.3 – 
98.2) 
+LR N/A N/A 25.06 (95% CI 
10.32 – 62.2) 
14.09 (95% CI 
6.533 – 30.41) 
-LR 0.44 (95% CI 
0.214 – 0.923) 
0.55 (95% CI 
0.398 – 0.755) 
0.29 (95% CI 
0.154 – 0.541) 
0.412 (95% CI 




CI 0.714 – 
0.833) 
(P=0.0027) 
0.726 (95% CI 
0.659 – 0.786) 
(P= 0.0001) 
0.846 (95% CI 
0.788 – 0.893) 
(P= 0.0001) 
0.781 (95% CI 
0.718 – 0.836) 
(P= 0.0001) 
 
LR +ve = positive likelihood ratio,  LR –ve = negative likelihood ratio,  ROC = 
receiver operator curve.  
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Histological confirmation of endometriosis was not possible in all cases as the study 
design did not state that histology was necessary.  However, where available the 
histology results are shown in table 15. Table 16 shows the distribution of the 
individual features of endometriosis according to the overall stage of disease. 
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Table 15. Histological confirmation of endometriosis in relation to 
severity. 
 
Severity None Minimal Mild Moderate Severe 
Total cases 62 33 31 27 48 
Histology 
available  
(%, 95% CI) 
9 (14.5, 
7.8- 25.3) 










(%, 95% CI) 
0 (0, 0- 
29.9) 
3 (43.9- 100 
%) 
7 (77.8, 45- 
93.7) 
25 (100, 
86.7- 100)  






Table 16. Distribution of features of endometriosis in relation to the 
overall severity of disease by rAFS at laparoscopy.  
 










Superficial peritoneal 33 22 16 28 
Deep peritoneal 0 17 17 37 
No endometriotic cysts 33 31 11 11 
cysts* <1cm 0 0 0 0 
cysts* 1-3cm 0 0 11 16 
cysts* >3cm 0 0 5 21 
Partial POD obliteration 0 0 7 12 
Complete POD obliteration 0 0 0 24 
Dense ovarian adhesions** <1/3 0 4 1 0 
Dense ovarian adhesions** 1/3-2/3 0 1 5 4 
Dense ovarian adhesions** >2/3 0 1 14 41 
Tubal adhesions (either side) 0 0 0 7 
Tubal dilatation (either side) 
dilatation 
0 2 0 2 
 
Features present which would upstage the disease under the newer system. 
 
* equals largest cyst on either ovary. 
** on either ovary which ever is worse affected 
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Fig. 14 demonstrates correlation of ultrasound and laparoscopic assessment of the 
severity of pelvic endometriosis as classified by rAFS. The inter-method correlation 
coefficient was 0.867 (95% CI 0.829-0.898). The mean difference between TVS and 
laparoscopy in assessing severity of endometriosis was -2.398 (95% CI -4.685 to -
0.1112) and the limits of agreement were -34.62 (95% CI -38.54 to -30.709) to 29.83 
(95% CI 25.91 to 33.74).  The difference is normally distributed as 95% of the values 
lie within 1.96 standard deviations of the mean.  Visual inspection of the scatterplot 
revealed that the magnitude of the difference did not change with increasing severity 
of endometriosis. (Fig. 15).  
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Figure 14:  A scatterplot of ultrasound and laparoscopic findings in 
individual women with and without evidence of pelvic endometriosis. 
The severity of the disease was determined using the rAFS 
classification.  

















Sample size 201 
Correlation coefficient r 0.8677 
Significance level P<0.0001 




Figure. 15.  Scatterplot of the difference in rASF score of the severity 
of endometriosis between TVS and laparoscopy versus mean score.  
 







































There were seven false negative cases for severe endometriosis: two were diagnosed 
as absent for endometriosis, one as minimal and four as moderate disease. The two 
cases of severe endometriosis which were classified as not having endometriosis both 
had the pouch of Douglas correctly classified as partially or completely obliterated by 
adhesions but the endometriotic nodules were not seen and there were no ovarian 
endometriomas present.  These cases were correctly classified as having severe 
adhesions but not as a consequence of endometriosis. The one case of severe disease 
which was classified as having minimal endometriosis had a rectovaginal septum 
nodule with an obliterated pouch of Douglas which was not seen on TVS.  Of the four 
cases of severe disease which were diagnosed as moderate disease three of them had 
the pouch of Douglas incorrectly classified as partially obliterated when it was 
completely obliterated and the other had ovaries which were fixed when they were 
classified as mobile. There were three cases of false positive for severe endometriosis: 
one had mild disease and the other two had moderate disease. The mild case had the 
pouch of Douglas misclassified as obliterated.  One of the moderate cases had smaller 
ovarian endometriomas at laparoscopy than on scan and the other had a unilateral 
endometrioma on laparoscopy when there were bilateral cysts on scan. There were 29 
false negative cases for minimal disease and 27 false negative cases for mild disease. 
The majority of these false negatives had superficial peritoneal disease only. 
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Discussion  
Our study confirms that transvaginal ultrasound is an accurate diagnostic method for 
the assessment of women with suspected pelvic endometriosis. We used the rASRM 
classification to assess the severity of endometriosis on both ultrasound and 
laparoscopy94. We chose this particular scoring system as it is a well-established 
standard and it is widely used in clinical practice for the assessment of pelvic 
endometriosis. There was a high level of agreement between transvaginal ultrasound 
and laparoscopy in assessing the severity of disease. The accuracy of ultrasound was 
94% in cases of moderate and severe pelvic endometriosis, however, the sensitivity of 
diagnosis in minimal and mild pelvic endometriosis was relatively low. Minimal 
endometriosis is characterised by the presence of small and superficial endometriotic 
lesions, which are difficult to detect on ultrasound or indeed on any other imaging 
modality. Mild disease, as defined by rASRM, can either be due to superficial disease 
or to isolated deeply infiltrating lesions.  These isolated lesions are especially difficult 
to diagnose as there are no other signs to raise the suspicion of their presence.  
Inspection of scatter plots of differences between ultrasound and laparoscopy showed 
that ultrasound is significantly biased towards underestimating the severity of 
endometriosis. The lower sensitivity of ultrasound in the diagnosis of superficial 
disease and isolated deeper nodules is likely to be the main factor contributing to this 
finding.  
The rASRM system has been criticised for scoring a maximum of six points for DIE 
of the peritoneum and no points being allocated for disease of the bowel80. This can 
raise the possibility of isolated DIE being given a low score although the symptoms 
and surgical difficulty would suggest a higher stage of disease. Other systems have 
been developed to complement the rASRM system but these are not widely known 
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and they are rarely used in routine clinical practice95,96 .  For these reasons we 
recommend stating the exact site and extent of any DIE found on either TVS or at 
surgery in addition to using the rAFS scoring system. Table 13 shows that with 
increasing severity of disease, DIE becomes more common and the sensitivity of TVS 
at diagnosing DIE also increases. 
An easier way of diagnosing severe disease would be to use the presence of DIE on 
the bladder, bowel or RVS or obliteration of the pouch of Douglas could be used as an 
alternative way of diagnosing severe endometriosis.  It could be argued that the 
detection of DIE in any of these locations amounts to severe disease and warrants 
surgery by an expert laparoscopic surgeon.  The sensitivity of ultrasound in the 
diagnosis of DIE in these locations varies between 45 and 72% but the specificity is 
very high, between 97 and 100% (Table 14). By adopting this approach the diagnosis 
of severe endometriosis on ultrasound becomes simpler and quicker. Table 5 shows 
accuracy of diagnosis of these features individually and the overall diagnosis of 
severe disease when any of these features are present. These results show that TVS is 
highly specific but less sensitive at diagnosing these features.  The moderate 
sensitivity is likely to be due to the difficulty in diagnosing isolated DIE without the 
presence of large endometriomas or severe adhesions to raise the suspicion of DIE.  
Histological diagnosis was not a condition of inclusion into this study and biopsies 
were not sent in all cases. However when biopsies were sent in moderate or severe 
cases endometriosis was confirmed.  Endometriosis was confirmed in 77.8% of mild 
cases when histology was available. 
Although, the diagnosis of moderate and severe disease was made with a high level of 
accuracy, there were occasional false positive and false negative findings.  The false 
negatives in general were due to difficulty in identifying DIE and in classifying pouch 
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of Douglas obliteration.  The high specificity of ultrasound diagnosis of endometriosis 
is an important finding. This indicates that women with evidence of severe disease 
could be referred for expert surgical treatment based on ultrasound findings alone 
without the need for confirmatory diagnostic laparoscopy.  
Ultrasound examinations in this study were performed by operators with a high level 
of expertise in gynaecological ultrasonography.  There was no significant difference 
in diagnostic accuracy between the two operators who performed the majority of 
ultrasound examinations in this study. This is in keeping with the findings of chapter 
7 (study 3). It remains to be seen whether the accuracy of ultrasound diagnosis of 
endometriosis will remain high when the examinations are performed by less 
experienced operators.  
Previous studies have shown that ultrasound is an accurate test to diagnose ovarian 
endometriomas16 . However, the results were less promising in cases of non-ovarian 
pelvic endometriosis. Some authors have advocated transrectal scans in order to 
improve ultrasound diagnosis of DIE. This technique was particularly helpful for the 
diagnosis of utero-sacral and intestinal endometriosis18-21,97 .   Bazot86  however, 
achieved better diagnosis of uterosacral and rectosigmoid endometriosis using 
transvaginal ultrasonography compared to the transrectal approach.   They also 
showed that TVS is very accurate in the diagnosis of intestinal and bladder 
endometriosis, but less so in detecting uterosacral, vaginal and rectovaginal septum 
involvement. Our results are concordant with their findings as we also had difficulties 
in identifying the disease in the rectovaginal septum. 
Okaro28 assessed ovarian mobility in terms of being either mobile or fixed. They 
described their method as mobilisation of the ovary with gentle pressure from the 
probe. They found a good level of agreement (kappa=0.80) between the scan 
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diagnosis and the laparoscopy findings.  We agree with their findings as we also 
found a high level of accuracy in assessing ovarian mobility.  Our study methods, 
however, differed in two ways to this study.  When assessing ovarian mobility we 
used a bimanual technique with gentle pressure from the probe and palpation across 
the abdominal wall with the examiners free hand.  Also we assessed for mild and 
moderate levels of adhesions in addition to fixed or completely mobile ovaries.  This 
is important, as a small amount of adhesions is easier to divide and therefore require 
less surgical skill.  However, our study could be criticised for using a subjective 
distinction between the levels of ovarian adhesions. This subjective classification may 
be a source of bias towards under or over estimating the level of adhesions and 
consequently the overall severity.  It is yet to be established whether these subjective 
criteria are reproducible in further inter observer studies.  
 
In our study some of the false positives and false negatives for severe disease came 
from the misdiagnosis of pouch of Douglas obliteration.  Bazot86 also found this to be 
a difficult diagnosis to make. They gave a TVS diagnosis rate of complete and partial 
obliteration of 23 and 11 patients respectively out of the study population of 142 
cases. At surgery they found 44 cases of complete obliteration and 13 cases of partial 
obliteration.  They defined pouch of Douglas obliteration as complete when “uterus, 
adnexa and rectosigmoid colon were stuck together with loss of peritoneal structure 
and incomplete when peritoneal limits were partially identified with presence or 
absence of suspended or lateralized fluid collection”. Our definition of obliteration is 
easier to use, however it is sometimes not an easy feature to assess accurately.   
Hudelist25  compared bimanual digital examination to TVS combined with bimanual 
examination.  They found that the combined technique gave very high levels of 
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accuracy and these were much higher than bimanual examination alone.  We did not 
perform digital examinations in our study and it may be that our sensitivities would be 
increased using a combined technique.  However this study does not compare TVS 
alone with the combined technique and therefore it may be that using their technique 
TVS may perform just as well as the combined technique. Abrao24 compared TVS 
with digital vaginal examination and MRI and found that TVS had better sensitivity, 
specificity and accuracy in cases of deep “retro-cervical” and rectosigmoid 
endometriosis when compared with the other two techniques.   
Guerriero98 studied a novel technique for diagnosing “deep endometriosis” which 
included vaginal and rectovaginal septum disease. This involved using 12mls of gel 
within the probe cover to create a stand-off to visualise the near field area.  Their 
sensitivity and specificity were 90% and 95% respectively and they concluded that 
this was an accurate and inexpensive technique for evaluating patients for deep 
endometriosis. This technique may have benefits over the standard TVS routines but 
it is more complex and would require a greater degree of operator skill and experience 
to be reliable. Further more this study suffers from selection bias as all the patients 
included were suspected of having deeply infiltrating rectovaginal endometriosis on 
clinical history or examination.  Therefore it is difficult to apply these findings to a 
population of women with chronic pelvic pain. It is thus unlikely that the accuracy of 
the technique described by Guerriero would be reproducible in our study due to the 
mix of patients with various grades of severity of endometriosis. Also a direct 
comparison with the standard routine would be required in order to conclude that this 
technique is superior. Our study, however, differs from previously published research 
in that we were attempting to establish the ability of TVS to give an overall 
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assessment of the severity of pelvic endometriosis, rather than trying to examine the 
accuracy in diagnosing individual morphological features of the disease.  
In a previous study99 examined the value of MRI for staging of pelvic endometriosis.   
This study used a scoring system based on the rAFS with modifications to allow for 
MRI interpretation.  They found a high degree of agreement between the MRI 
findings and operative findings (κ =0.916) with concordant staging in 42 of 44 
patients. The authors recognised, however, that MRI is not a good test to diagnose 
adhesions or complete obliteration of the pouch of Douglas. In some cases 
endometriotic nodules were not seen on MRI and superficial disease was almost 
impossible to assess, which is similar to the results of our study using TVS.  Although 
it is clear that both MRI and TVS are to some extent limited in the assessment of 
pelvic endometriosis, the ability of TVS to examine for the presence of adhesions 
directly using dynamic manipulation of the pelvic organs may be an important 
advantage over MRI. 
Our study is limited by a lack of agreement regarding the classification of severe 
endometriosis. The rAFS classification, which we used in our study, does not provide 
a very accurate description of deep infiltrating endometriosis. Although this is clearly 
an important limitation, none of the other systems to assess the severity of 
endometriosis is widely used in clinical practice and for this reason we have used the 
most widely accepted standard, the rAFS classification. As has been described 
previously this is useful for fertility assessment but is less good at assessing the 
difficulty involved in complete resection. Our study is also limited by the fact that 
gynaecologists with significant experience of in diagnostic ultrasound and 
endometriosis performed all of the TVS.  This makes the conclusions difficult to 
extrapolate to other centres where the level of experience may not be as high.   
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In conclusion, our study has shown that a targeted transvaginal ultrasound scan is an 
accurate test to diagnose severe pelvic endometriosis. This implies that in women 
with evidence of severe disease on ultrasound, a confirmatory diagnostic laparoscopy 
may not be required and these women could be referred directly to an expert 
minimally invasive endometriosis surgeon locally or a regional tertiary referral 
endometriosis centre. This approach could facilitate more effective triaging women of 





Chapter 9 Study 4 
The value of symptomatology and tenderness in 




The clinical presentation of endometriosis is variable: some women experience 
several severe symptoms whilst others experience no symptoms at all and are 
diagnosed incidentally during a procedure such as laparoscopic sterilisation 100-102 . In 
addition, many of the symptoms of endometriosis such as dysmenorrhoea and deep 
dyspareunia are common in women of reproductive age and could be caused by a 
number of pathologies such as adenomyosis, adhesions, infections, or where no 
organic cause can be found. 
 
A variety of studies have attempted to address the apparent lack of correlation 
between symptomatology and presence, location and severity of pelvic endometriosis 
on laparoscopy. Epidemiological data2 suggests that dysmenorrhoea, deep dysparunia 
and non-cyclic pelvic pain are all more likely to occur in patients with endometriosis 
than in those without.  In a large primary care based study103 which included 5540 
cases, with over 10000 controls, it was found that dysmenorrhoea, pelvic pain, 
dysparunia and menorrhagia were strongly correlated with a diagnosis of 
endometriosis and had odds ratios of 9.8, 13.5, 9.4 and 5.0 respectively.  
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However, the direct relationship between types of pain and types of lesion found is 
less clear 104-108.  No relationship was found between the ASRM stage of disease and 
the severity of pain109 .  Fauconnnier82 found that severe dysmenorrhoea was 
associated with an increase in pouch of Douglas adhesions, dyspareunia with 
uterosacral ligament lesions, non cyclic pain with bowel lesions and dyschezia with 
deeply infiltrating endometriosis lesions (DIE) of the vagina.   Koninckz110 found that 
the depth of invasion of DIE related to severity of pain. Porpora 109 found that pain 
was only associated with ovarian endometriomas when adnexal adhesions were 
present. 
  
No previous studies have examined if symptomatology can be used in conjunction 
with the findings at transvaginal ultrasound examination to improve the diagnostic 




The aims of this study were:  
• to examine if it is possible to predict the presence and severity of pelvic 
endometriosis from the symptomatology and tenderness at TVS 
• to examine if the addition of symptomatology and tenderness at TVS can help 
in the diagnosis of pelvic endometriosis in patients who have false negative 
findings for pelvic endometriosis at transvaginal ultrasound examination, and 
in doing so establish which patients would benefit from laparoscopy in spite of 
a normal TVS result.  
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Methods and statistical analysis 
The methodology for this study was similar to the previous chapters.  The symptoms 
which are associated with pelvic endometriosis of dysmenorrhoea, deep dysparunia, 
non-cyclic pelvic pain, menorrhagia, infertility, painful defaecation (dyschezia) and 
cyclic rectal bleeding were recorded prospectively.   Tenderness was assessed on TVS 
by the examiner asking the patient to inform them of any tenderness throughout the 
scan. These symptoms were then used to build logistic and multivariate regression 
models for the presence and stage of pelvic endometriosis respectively. Kruskal 
Wallis rank correlation was used to assess the correlation that each feature had with 
the stage of endometriosis at laparoscopy. Logistic regression analysis was used to 
assess the predictive value of each subjective feature for the presence of 
endometriosis.  Multiple regression analysis was used to assess the predictive value of 




In the period of 38 months from July 2006 to September 2009 we recruited 237 
women into this study. 39 women were excluded from the final analysis: twenty nine 
because they were not assessed by one of the two designated ultrasound operators, 
five became pregnant whilst awaiting surgery, one cancelled her operation, one 
laparoscopy was unsuccessful and three women were lost to follow up.  
198 women were included in the final analysis. The mean age was 35.0 (95% CI 
33.98 – 35.97, SD 7.10) (range 19-50) years. The presenting symptoms were 
dysmenorrhoea for 143/198 (72.2%), chronic pelvic pain for 98/198 (49.5%), 
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dyspareunia for 91/198 (45.9%), infertility for 42/198 (21.2%) and dyschezia for 
18/198 (9.6%) women.  Tenderness was found on ultrasound examination in 57/198 
(28.8%) of women. A single presenting symptom was present in 72 (36.4%) women, 
two presenting symptoms in 66 (33.3%), three presenting symptoms in 39 (19.7%), 
four or more symptoms in 19 (9.6%) women.  
 
The ultrasound examinations were performed by two examiners: examiner A 
performed 104 (52.5%), examiner B 94 (47.5%). All patients were operated on by one 
of four laparoscopic surgeons: surgeon A operated on 79 (39.9%), surgeon B on 54 
(27.3%), surgeon C on 35 (17.7%) and surgeon D on 30 (15.2%) women. The mean 
interval between TVS and operation was 36.8 days (95% CI 33.4 – 41.1, SD 22.9) 
(range 0-87 days).  
 
Table 17 shows the frequency of the symptoms and tenderness on TVS in relation to 
the ASRM stage of endometriosis. When the significance level (P) was calculated 
using the Kruskal- Wallis test for correlation only dyschezia and dysmenorrhoea were 
significantly associated.  The association with infertility neared significance 
(P=0.053).  Figure 16 shows the data from table 17 as bar graphs for each symptom 
and tenderness in relation to the stage of endometriosis.   
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Table 17.  The frequency of symptoms of endometriosis and 
tenderness on TVS in relation to ASRM stage of endometriosis. 
(Absent, minimal, mild, moderate or severe).  P calculated using 
Kruskal- Wallis test for correlation. 
 
 




Figures 16-22 Bar graphs of mean number of patients who have each symptom and 







































































































P 0.0103* 0.6253 0.3456 0.0534 0.9388 0.0072* 0.2452 
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Table 18 shows the multivariate regression for how the symptoms and tenderness on 
TVS correlate with the ASRM stage at laparoscopy. The presence in the history of 
dysmenorrhoea, dyschezia and infertility were all significantly associated with the 
stage of endometriosis.  Dysparunia was negatively associated with the stage of 
endometriosis.  Menorrhagia, pain when not menstruating and tenderness on TVS 
were not significantly associated with the stage of endometriosis.   
 
Table 18 Results of multivariate analysis of the prediction of ASRM 
stage according to symptoms and tenderness on TVS.  
 
 Coefficient Std.Error T P 
Constant 0.7463       
Dyschezia 0.9804 0.3994  2.454 0.0150* 
Dysmenorrhoea  0.8681 0.2670  3.252 0.0014* 
Dysparunia  -0.4697 0.2292  -2.049 0.0418* 
Infertility 0.7876 0.2799  2.814 0.0054* 
Menorrhagia 0.07125 0.3211  0.222 0.8246 
Non cyclic pain 0.3607 0.2315  1.558 0.1208 
Tenderness 0.4155 0.2556  1.626 0.1057 
Dependent variable: ASRM stage  R2 = 0.1493  (P < 0.001). 
* = P< 0.05 
 
Table 19 shows the frequency of the sum of the presence of dysmenorrhoea, infertility 
and dyschezia in relation to the stage of endometriosis at laparoscopy.  
 
Table 19. Table of the stage at laparoscopy and the numerical sum of 
the presence of dysmenorrhoea, infertility, and dyschezia (sum of 3 
symptoms). 
 
Stage at laparoscopy Sum of 3 
symptoms 0 (n= 72) 1 (n= 35) 2 (n= 19) 3 (n= 18) 4 (n= 54) 
0 (n= 46) 24 9 5 5 3 
1 (n= 101) 39 18 12 8 24 
2 (n= 48) 9 8 2 4 25 




Figure 2 is a bar graph of the mean of the sum of the presence of dysmenorrhoea, 
infertility, and dyschezia (sum of 3 features).   The coefficient of correlation was 
0.3279 (95% CI 0.1974 to 0.4469) P<0.0001.  The addition of non cyclic pelvic pain  
(ie the sum of 4 features) gave a coefficient of correlation = 0.3253 (95% CI 0.1947 to 
0.4446) P<0.0001.  As the coefficient of correlation was less with the addition of 
cyclic pelvic pain this has not been included in the table.  Although there is a strong 
correlation between the sum of these symptoms and the stage this is only suggestive 
clinically as there was considerable overlap between the stages.   However, all three 
symptoms were only present in stage 3 and 4 disease.  Also with none of these 
symptoms present there was a 24/46 (52%) chance of having no disease found.  With 
2 of these symptoms there was a 25/48 (52.1%) chance of having stage 4 disease.   
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Figure 23. Bar graph of the correlation between the stage at 
laparoscopy and the mean of the numerical sum of the presence of 
dysmenorrhoea, infertility, and dyschezia (sum of 3 features).  
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Coefficient of correlation = 0.3279 (95% CI 0.1974 to 0.4469) P<0.0001 
The addition of non cyclic pelvic pain  (ie the sum of 4 features) gave a coefficient of 
correlation = 0.3253 (95% CI 0.1947 to 0.4446) P<0.0001.   
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Table 20 shows the results of logistic regression analysis for the presence or absence 
of endometriosis on ultrasound.  This shows that only dyschezia was a significant 
predictor for the presence of endometriosis on laparoscopy.    
 
 
Table 20 Results of logistic regression analysis for the symptoms and 
tenderness on TVS with respect to presence of endometriosis at 
laparoscopy.  
 
Symptoms Coefficient Std.Error P Odds Ratio 95% CI 
Constant  -0.06166     
Dyschezia 2.4312 1.0569 0.02143* 11.3721 1.4328 to 90.2587 
Dysmenorrhoea 0.6506 0.3625 0.07267 1.9167 0.9419 to 3.9003 
Dysparunia -0.4851 0.3209 0.1306 0.6156 0.3282 to 1.1546 
Infertility 0.6395 0.4103 0.1190 1.8956 0.8482 to 4.2362 
Menorrhagia 0.2377 0.4585 0.6041 1.2684 0.5164 to 3.1153 
Non cyclic pain 0.1566 0.3302 0.6353 1.1695 0.6122 to 2.2341 
Tenderness on 
TVS 
0.05935 0.3569 0.8679 1.0611 0.5272 to 2.1358 
 
 
As TVS has a low sensitivity especially when assessing minimal and mild 
endometriosis we attempted to establish if the symptomatology and tenderness could 
improve upon the sensitivity of TVS for endometriosis.  We took all of the patients 
who did not have endometriosis found at TVS and assessed to establish if the addition 
of the symptomatology and tenderness on TVS would improve the diagnosis of both 
the presence or the stage of disease. We found that neither the symptoms nor 
tenderness on TVS were predictive of the presence or stage of endometriosis in 
patients who had a negative TVS.  In addition only the presence of tenderness on TVS 
showed a significant increase in frequency with stage of disease in these patients.  
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When the predictive value of the symptoms and tenderness were assessed using 
logistic regression for the presence of individual locations for deeply infiltrating 
endometriosis (DIE) we found significant associations between: rectovaginal disease 
and dysmenorrhoea and tenderness; pouch of Douglas obliteration and infertility and 
dysmenorrhoea; pelvic side wall disease and menorrhagia; uterosacral ligament DIE 
and tenderness.  Dysparunia was negatively associated with DIE of any location.  
There were no significant predictors for utero vesical fold, bladder or bowel DIE.   
These findings are detailed in table 21 and summarised in table 22.  
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Table 21.  Results of logistic regression analysis for significant 
predictors of deeply infiltrating endometriosis (DIE) in various 
locations. 
 
Location of DIE Predictor Coefficient Std.Error P Odds Ratio 95% CI for 
OR 
DIE of any location Dysparunia -0.7290 0.3714 0.04965 0.4824 0.2330 to 
0.9989 
Dysmenorrhoea 1.3799 0.6729 0.0403 3.9744 1.0629 to 
14.8610 
Rectovaginal septum 
Tenderness 1.1197 0.5047 0.0265 3.0640 1.1395 to 
8.2387 
Dysmenorrhoea 1.2795 0.5183 0.01357 3.5950 1.3016 to 
9.9293 
Infertility 1.7487 0.4623 0.0001552 5.7469 2.3224 to 
14.2212 
Pouch of Douglas 
partial or complete 
obliteration 
Tenderness 0.8815 0.4563 0.05336 2.4146 0.9873 to 
5.9054 
Dysmenorrhoea 1.6271 0.7939 0.04043 5.0889 1.0735 to 
24.1231 
Pouch of Douglas 
complete 
obliteration Infertility 1.9247 0.5569 0.0005476 6.8530 2.3008 to 
20.4123 
Pelvic Side Wall Menorrhagia 1.7907 0.8943 0.04523 5.9938 1.0387 to 
34.5866 
Uterosacral ligament Tenderness 1.0475 0.5217 0.04464 2.8506 1.0254 to 
7.9251 




Table 22.  Results showing positive and negative predictors of deeply 
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This study has shown that the frequency of dysmenorrhoea, infertility and dyschezia 
are associated with the stage of endometriosis at laparoscopy according to the ASRM 
classification.  In addition the sum of these three symptoms is strongly associated 
with the stage of disease.  However, our findings show that deep dysparunia, non 
cyclic pelvic pain, menorrhagia and tenderness on TVS were not associated with the 
stage of endometriosis at laparoscopy nor with the presence or absence of 
endometriosis at laparoscopy.   In addition none of these features helps improve the 
TVS pickup rate of minimal and mild disease in women who have a negative TVS.   
 
These findings are in contrast with Porpora109  who showed that the severity of 
symptoms did not correlate with ARSM stage of disease.  However, they were using 
visual analogue scores to assess the severity of the symptoms rather than the presence 
of individual symptoms.  
 
However, although the frequency of certain symptoms does increase with the stage of 
disease there is still a moderate frequency of these symptoms (apart from dyschezia) 
in women without endometriosis.  In our data set only a history of dysmenorrhoea 
with infertility and dyschezia is strongly predictive of moderate to severe disease.  A 
combination of two of these symptoms makes a diagnosis likely but by no means 
certain. This means that a detailed history of symptomatology alone will only increase 
the likelihood of disease if these symptoms are present but will not allow for an 
accurate diagnosis of the presence or stage of endometriosis based on history alone.  
Also the small numbers of patients in our dataset means that firm conclusions are 
difficult to be certain of without validating the findings with a larger dataset.   
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When the symptoms were correlated with individual locations of deeply infiltrating 
endometriosis (DIE) there were some strong associations.  We did not find that 
dyschezia was a predictor of any location of DIE.  This is in contrast to Fauconnier82  
who found that dyschezia was related to DIE of the vagina.  In this study they found a 
correlation between deep dysparunia and uterosacral ligament disease (USL).  In 
contrast our data showed a negative correlation between deep dyparunia and USL 
involvement but this was not statistically significant.  Deep dysparunia was common 
in the women found not to have any endometriosis at surgery.  This may be explained 
by the complex nature of sexual symptoms. The only finding which was significantly 
associated with USL involvement was tenderness during the TVS examination.  
Dysmenorrhoea and infertility were strong predictors of partial and complete pouch of 
Douglas obliteration.  This agrees with the findings of Fauconnier82  who found an 
association with dysmenorrhoea and pouch of Douglas obliteration.  
 
Unfortunately when all of the patients who were correctly diagnosed with 
endometriosis on TVS were removed from the analysis in order to assess the benefit 
of the addition of symptomatology to TVS we did not find any strong associations.  
This means that there is minimal benefit offered by assessing the symptoms over and 
above a detailed TVS by a gynaecologist with expertise in assessing pelvic 
endometrioisis.  However, a detailed history is always worth assessing as for 
sonographers who are less familiar with assessing severe endometriosis a history of 
dysmenorrhoea, infertility and dyschezia would suggest that there is likely to be 
significant endometriosis and will make the diagnosis easier.   Experienced ultrasound 
 128 
operators will also benefit from taking a full symptom history in that they will have a 
good idea of what they will find before starting the ultrasound assessment. 
   
One of the major limitations with this study is that the symptoms and assessment of 
tenderness were assessed by the Gynaecologist who was performing the ultrasound.  
This is a potential source of inaccuracy and it would have been more reliable if the 
patients had filled out detailed validated quality of life questionnaires including a 
detailed assessment of symptoms.  It would also have been better if patients were 
asked to give a visual analogue score for tenderness in various locations during the 
TVS examination.  Both of these measures would have reduced potential sources of 
bias.   
 
Conclusions 
The frequency of dysmenorrhoea, dyschezia and infertility increased with the ASRM 
stage of endometriosis.  The presence of two or more of these symptoms is suggestive 
of advanced endometriosis.  The overall number of symptoms also increases with 
stage. Dyspareunia was negatively associated with the stage of endometriosis.  
Menorrhagia, pain when not menstruating and tenderness on TVS were not 
significantly associated with the stage of endometriosis.  Certain symptoms are 
associated with certain locations of DIE.   The symptomatology does not help in 
diagnosing minimal and mild endometriosis in patients who have no signs of 
endometriosis found on TVS.   
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Chapter 10 Study 5 
The use of serum CA125 in addition to TVS for the 
diagnosis of presence and severity of endometriosis  
when compared with laparoscopy.  
 
Introduction 
It has been shown in the previous chapters that transvaginal ultrasound is valuable for 
the preoperative diagnosis of more advanced endometriosis.  The addition of 
subjective aspects of assessment such as patient symptomatology and tenderness on 
examination with the transvaginal probe do not add significantly to the accuracy of 
the ultrasound diagnosis.  Serum markers have been investigated for their role in the 
evaluation of endometriosis with limited results 63,64,66,67,71,111-129 .   No single serum 
test or combination of tests has as yet given a highly sensitive and specific test to 
stage or exclude pelvic endometriosis.  The elevation of cancer antigen 125 (CA125) 
in association with endometriosis has been know about since the mid 1980s63,130 
Cancer antigen 125 is a high molecular weight mucin glycoprotein which is encoded 
by the MUC16 gene.  It was first discovered by Bast in 198156. This protein plays a 
role as a lubricating barrier against foreign particles and infectious agents on the 
surface of many epithelial cells. This protein is expressed by a few normal tissues 
such as the endometrium, fallopian tube epithelium, lung parenchyma and cornea131 . 
When there is rapid production or turnover of these cells, for example due to 
inflammation or malignancy, this surface antigen in released into the blood. This has 
given rise to its use in the detection of ovarian cancer. However, any condition which 
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causes irritation of the peritoneum, pericardium or pleura can elevate the levels. 
Benign conditions which increase the production of CA125 include pregnancy, 
fibroids, pelvic inflammatory disease, congestive cardiac failure with pleural 
effusions and endometriosis.  
 
The association between raised CA125 levels and pelvic endometriosis has been 
know since 1986 and since then many studies have attempted to elucidate the exact 
relationship and clinical usefulness of this test.  A meta-analysis performed by Mol63 
found 23 studies which investigated the use of CA125 as a non invasive test for the 
presence and stage of endometriosis.  The sensitivies of these studies ranged between 
0.16 and 1.00 and the specificities ranged between 0.38 and 1.00.    The meta analysis 
found that measurement of CA125 was more accurate at diagnosing stage 3-4 disease 
than stage 1-2. In addition there was difficulty in the meta – analysis in finding the 
CA125 level at which the accuracy is greatest over all 23 studies.   The higher the 
level then the higher the specificity will be but sensitivity will be sacrificed.   
However most of the quoted studies used a CA125 level of 35 IU/ml as a cutoff level.  
No studies have used CA125 in conjunction with TVS to diagnose the presence and 




To assess the value of serum CA125 for the diagnosis of presence and severity of 





This prospective observational study was conducted at King’s College Hospital Early 
Pregnancy and Gynaecology Assessment Unit.  Subjects were recruited consecutively 
from April 2007 to September 2008.  The study was approved by the Ethics 
Committee and the Research & Development Committee for this hospital.  
 
Patients 
Consecutive women with chronic pelvic pain, defined as pelvic pain for more than six 
months duration, who were due to be admitted for a diagnostic laparoscopy were 
asked to donate a blood sample.  Patients were recruited from the Early Pregnancy 
and Gynaecology Assessment Unit at King’s College Hospital.  The inclusion criteria 
were: all women referred with a clinical suspicion of endometriosis and booked for a 
diagnostic laparoscopy; written informed consent obtained; aged 16 or over. 
Exclusion criteria were: previous proven endometriosis at laparoscopy or other pelvic 
surgery;  unable to comprehend study and provide informed consent. 
 
An information leaflet about the study was given to all eligible patients before 
assessment. Written informed consent was obtained from all patients who agreed to 
take part in the study. 
 
Procedure 
Data, including age, parity and gravidity and the name of the examining doctor were 
recorded.  A detailed clinical history was recorded including symptomatology 
associated with endometriosis such as dysmenorrhoea (painful periods), dysparunia 
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(painful sexual intercourse), menorrhagia (heavy or prolonged periods), dyschezia 
(painful defecation), infertility (for greater than one year), and cyclic rectal bleeding.   
 
Women were given a blood form and asked to return to have the blood taken from a 
peripheral vein on day 1 of the menstrual cycle (the first day of bleeding).  If day one 
of the menstrual cycle was on a Saturday or a Sunday they were asked to come on the 
Monday. Blood samples were taken by the phlebotomy service of King’s College 
Hospital. Blood was Centrifuged at was centrifuged at 300 rpm for 15 mins and 
separated into six aliquots. Within two hours of collection samples were stored at -
30oC and transferred to –70oC within 24 hours. The samples were analysed for 
CA125 with the Immuno-1 analyser (Bayer diagnostics, Tarrytown, NY, USA).  The 
exact method used in the analysis of these samples is in the appendix.  
 
A database file was set up using Microsoft Excel for Windows spreadsheet to 
facilitate data entry and retrieval. Univariate analyses were carried out using the 
MedCalc software package using the Mann–Whitney test and Kruskal–Wallis test 
with Dunn’s multiple comparison test. Additionally, receiver operating characteristic 
(ROC) curves were constructed.   
 
All patients had their laparoscopies performed at Kings College Hospital. The 
severity of endometriosis was recorded in accordance with the revised American 
Fertility Society guidelines1985 7.  This includes a detailed description of the 
presence and extent of endometriosis affecting the peritoneum, ovaries, tubes, and 
pouch of Douglas.  Each element is given a score depending on severity.  The 




67 patients were recruited.  Of these 30 patients returned for their serum to be 
sampled on day 1-3 of the menstrual cycle. 37 patients did not return to have serum 
sampled and are excluded from the analysis.   These were analysed on the day of 
collection but the results were sent to the research team only.  
 
The mean age of the patients was 34.0 years (95% CI 29.8 to 37.6) with a range of 19 
to 49 years and standard deviation of 7.62 years.  
 













The correlation coefficient for the CA125 values vs the ASRM stage of 
endometriosis,  the ASRM score and the presence or absence of endometriosis, is 
shown in table 23.  This shows that there was a statistically significant correlation 
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between the CA125 level and the stage of endometriosis but not with the presence or 
absence of disease.  However the Mann-Whitney test (table 24) for difference 
between the mean of two groups shows a significant difference in the values between 
the two groups.    
 
Table 23.  Results of correlation coefficient coefficient data for 
CA125 compared with the ASRM stage and score and the presence 
or absence of endometriosis. 
  
CA125 correlated with: Correlation 
coefficient r 
95% CI for r P value 
ARSM stage at laparoscopy (0-
4) 
0.5651 0.257 to 0.768 0.0011 
ASRM score at laparoscopy 0.4336 0.087 to 0.687 0.0167 
Presence of endometriosis (N/Y) 0.2744 -0.095 to 0.578 0.1423 
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Figure 25 box plot of Log CA125 results separated into two groups: 
patients with endometriosis present and those without endometriosis 
at laparoscopy.   
 
Box plot of Log Ca125 result 









Table 24. Results of Mann-Whitney test for difference between those 
with endometriosis and those without.   




Sample size 12 18 
Lowest value 5 6 
Highest value 43 266 
Median 8 18 
95% CI for the median 6.55 to 12.82 9.69 to 33.25 
Interquartile range 7 to 11 10 to 28 
Two-tailed probability P=0.0033 
 
Table 25.  Results of CA125 values and coordinates on the ROC 
curve. 
CA125 value Sensitivity 95% CI Specificity 95% CI +LR    -LR 
>=5 100.00 81.3 - 100.0 0.00 0.0 - 26.6 1.00   
>5 100.00 81.3 - 100.0 8.33 1.4 - 38.5 1.09 0.00 
>6 94.44 72.6 - 99.1 16.67 2.6 - 48.4 1.13 0.33 
>7 94.44 72.6 - 99.1 33.33 10.1 - 65.1 1.42 0.17 
>8 88.89 65.2 - 98.3 66.67 34.9 - 89.9 2.67 0.17 
>9 77.78 52.4 - 93.5 66.67 34.9 - 89.9 2.33 0.33 
>10 72.22 46.5 - 90.2 66.67 34.9 - 89.9 2.17 0.42 
>11 * 72.22 46.5 - 90.2 83.33 51.6 - 97.4 4.33 0.33 
>15 61.11 35.8 - 82.6 91.67 61.5 - 98.6 7.33 0.42 
>16 55.56 30.8 - 78.4 91.67 61.5 - 98.6 6.67 0.48 
>17 50.00 26.1 - 73.9 91.67 61.5 - 98.6 6.00 0.55 
>19 44.44 21.6 - 69.2 91.67 61.5 - 98.6 5.33 0.61 
>21 38.89 17.4 - 64.2 91.67 61.5 - 98.6 4.67 0.67 
>22 33.33 13.4 - 59.0 91.67 61.5 - 98.6 4.00 0.73 
>23 27.78 9.8 - 53.5 91.67 61.5 - 98.6 3.33 0.79 
>28 22.22 6.5 - 47.6 91.67 61.5 - 98.6 2.67 0.85 
>43 22.22 6.5 - 47.6 100.00 73.4 - 100.0   0.78 
>45 16.67 3.8 - 41.4 100.00 73.4 - 100.0   0.83 
>54 11.11 1.7 - 34.8 100.00 73.4 - 100.0   0.89 
>122 5.56 0.9 - 27.4 100.00 73.4 - 100.0   0.94 
>266 0.00 0.0 - 18.7 100.00 73.4 - 100.0   1.00 
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Figure 26. ROC curve for the CA125 value in relation to the 
diagnosis of the presence of endometriosis.  
 
Ca 125














The highest point of accuracy is marked by the point which corresponds to a CA125 




From table 25 it can be seen that for a level of CA125 above 8 U/ml this gives a 
sensitivity of 88.9 % and a specificity of 66.7 %.  This would mean that at this cut off 
level approximately one patient would be missed in every ten with endometriosis and 
out of three patients who were offered a laparoscopy two patients would have 
endometriosis.   
 
When the stage of endometriosis was considered there was a significant increase in 
CA125 levels with the stage, Kruskal-Wallis rank correlation P=0.0099.  
 
When the CA125 data was used to assess for stage 3 or 4 endometriosis (Figure 28) 
the results were more accurate than assessing for just the presence of disease.  The 
results (table 26) show that for a cut off level of CA125 >11 U/ml the sensitivity of 
detecting stage 3 to 4 disease would be 100% and the specificity would be 65.2%.  
Therefore at this cut off level no patients with moderate to severe disease would be 
missed and approximately 3 laparoscopies would be performed to pick up two cases 
of moderate to severe disease. 
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Figure 27.  Scatter plot of log CA125 result in relation to the ASRM 
















Figure 28. ROC curve for the CA125 value in relation to the 
diagnosis of the presence of stage 3 or 4 endometriosis. 
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The highest point of accuracy is marked by the point which corresponds to a CA125 





Table 26.  Results of CA125 values and coordinates on the ROC 
curve. 
CA125 value Sensitivity 95% CI Specificity 95% CI +LR    -LR 
>=5 100.00 58.9 - 100.0 0.00 0.0 - 15.0 1.00   
>5 100.00 58.9 - 100.0 4.35 0.7 - 22.0 1.05 0.00 
>6 100.00 58.9 - 100.0 13.04 2.9 - 33.6 1.15 0.00 
>7 100.00 58.9 - 100.0 21.74 7.5 - 43.7 1.28 0.00 
>8 100.00 58.9 - 100.0 43.48 23.2 - 65.5 1.77 0.00 
>9 100.00 58.9 - 100.0 52.17 30.6 - 73.2 2.09 0.00 
>10 100.00 58.9 - 100.0 56.52 34.5 - 76.8 2.30 0.00 
>11 * 100.00 58.9 - 100.0 65.22 42.7 - 83.6 2.87 0.00 
>15 85.71 42.2 - 97.6 73.91 51.6 - 89.7 3.29 0.19 
>16 85.71 42.2 - 97.6 78.26 56.3 - 92.5 3.94 0.18 
>17 71.43 29.3 - 95.5 78.26 56.3 - 92.5 3.29 0.37 
>19 71.43 29.3 - 95.5 82.61 61.2 - 94.9 4.11 0.35 
>21 57.14 18.8 - 89.6 82.61 61.2 - 94.9 3.29 0.52 
>22 57.14 18.8 - 89.6 86.96 66.4 - 97.1 4.38 0.49 
>23 57.14 18.8 - 89.6 91.30 71.9 - 98.7 6.57 0.47 
>28 57.14 18.8 - 89.6 95.65 78.0 - 99.3 13.14 0.45 
>43 57.14 18.8 - 89.6 100.00 85.0 - 100.0   0.43 
>45 42.86 10.4 - 81.2 100.00 85.0 - 100.0   0.57 
>54 28.57 4.5 - 70.7 100.00 85.0 - 100.0   0.71 
>122 14.29 2.4 - 57.8 100.00 85.0 - 100.0   0.86 




However all of the cases of stage 3 and 4 disease in this study were correctly 
diagnosed on TV ultrasound scan and therefore the added benefit for these patients of 
an additional test is minimal.  We wanted to establish if patients who have no 
abnormality found at TVS would benefit from a serum test to improve the pick up rate 
of endometriosis.  The patients who had disease positively identified on scan were 
excluded from the data set and then the data was analysed as follows. 
 
Positive diagnosis of endometriosis on scan excluded.  
Three patients had stage 3 disease and 4 patients had stage 4 disease.  These were 
excluded from the results and this left 23 patients.    10 of these patients had stage 1-2 
disease found at laparoscopy and 13 had no disease found.    The results in figure 6 
and table 4 show that when the correctly diagnosed stage 3 and 4 patients were 
removed from the analysis CA125 does not perform as well at distinguishing between 
those who have endometriosis and those without.  However, a CA125 result cut off of 
> 8 U/ml would give a sensitivity of 70% and a specificity of 53 % for detecting stage 
1 and 2 disease and therefore this would give more confidence to recommend 
laparoscopy for these patients.   
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Figure 29. Scatter plot of log CA125 result with stage of 












Figure 30.  Box and whisker plot of all patients with a negative scan.  














Figure 31. ROC curve for the CA125 value in relation to the 
diagnosis of the presence of Stage 1 and 2 endometriosis (Patients 
correctly diagnosed at TVS excluded). 
 
 
The highest point of accuracy is marked by the point which corresponds to a CA125 



















Table 27.  Results of CA125 values and coordinates on the ROC 
curve. 
CA125 value Sensitivity 95% CI Specificity 95% CI +LR    -LR 
>=5 100.00 69.0 - 100.0 0.00 0.0 - 24.9 1.00   
>5 100.00 69.0 - 100.0 7.69 1.3 - 36.1 1.08 0.00 
>6 80.00 44.4 - 96.9 7.69 1.3 - 36.1 0.87 2.60 
>7 80.00 44.4 - 96.9 23.08 5.3 - 53.8 1.04 0.87 
>8 70.00 34.8 - 93.0 53.85 25.2 - 80.7 1.52 0.56 
>10 40.00 12.4 - 73.6 53.85 25.2 - 80.7 0.87 1.11 
>15 * 40.00 12.4 - 73.6 84.62 54.5 - 97.6 2.60 0.71 
>19 20.00 3.1 - 55.6 84.62 54.5 - 97.6 1.30 0.95 
>22 20.00 3.1 - 55.6 92.31 63.9 - 98.7 2.60 0.87 
>28 0.00 0.0 - 31.0 92.31 63.9 - 98.7 0.00 1.08 






Our results have shown a significant association (P=0.0011) between the ASRM stage 
of endometriosis and the CA125 level.  There was also a significant difference 
between the mean CA125 levels in those patients with endometriosis and those 
without, however there was considerable overlap in the results between the two 
groups therefore making the clinical usefulness uncertain.  Our results also show a 
reasonable accuracy of diagnosing stage 3 and 4 endometriosis with a sensitivity of 
100% and specificity of 65.2% at a CA125 cut off level of >11 (level of greatest 
accuracy) and a sensitivity of 85.7% and specificity of 78.3% at a CA125 cut off level 
of >16.  At a CA125 cut off level of 35 the sensitivity would be 57.1% with and 
specificity of 95.7%.    For the presence of disease at any stage at a cut off level of 
CA125 >11 the sensitivity is 72.2% and the specificity is 83.3 and at a cut off level of 
>35 the sensitivity is 22.2% and the specificity is 91.7%.   
 
These results are in agreement with the Meta-analysis performed by Mol63 (Ref Mol) 
which showed that the CA125 is a better discriminator for stage 3 and 4 disease than 
stage 1 and 2 disease.  In this study the test’s performance in diagnosing all disease 
stages was limited: the estimated sensitivity was only 28% for a specificity of 90% 
(corresponding likelihood ratio of a raised level is 2.8). The test’s performance for 
moderate–severe endometriosis was better: for a specificity of 89%, the sensitivity 
was 47% (corresponding likelihood ratio of a raised level is 4.3).  However, most of 
the studies included in this meta-analysis used a CA125 cut off level of 35IU/ml. 
 
An interesting study by Kafali64 looked at 28 patients who were having laparoscopies 
for infertility.  CA125 levels in the menstrual phase of the cycle were  compared with 
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CA125 levels in the rest of the cycle.  They found that there was no difference in the 
patients who did not have endometriosis but there was a large difference in patients 
who did have endometriosis.  Using a cutoff point of an 83% increase in CA125 
levels between the menstrual and the non menstrual phase of the cycle gave 
sensitivity of 93% and a specificity of 92% specificity.  All of the endometriosis 
found was either stage 1 or 2.  This study however has small numbers and the results 
would need to be repeated in larger studies before the clinical usefulness could be 
established. 
 
Since then there have been studies to further investigate the role of CA125 in the 
diagnosis of deeply infiltrating endometriosis as separate from ovarian disease.  In a 
cohort study by Patrelli65 serum CA-125 values were significantly elevated in patients 
with ovarian and mixed endometriosis lesions (median levels 48 U/mL), compared 
with those who had exclusively extraovarian foci (median levels 27 U/mL), however 
the location did not affect the subsequent fertility rate after 2 years of follow up.  
However, all of the included patients had proven endometriosis and 94% of their 
patients had stage three or four disease which suggests that this study population was 
more typical of a tertiary referral centre and the results are not applicable to the 
general population with suspected endometriosis due to the symptoms.   
 
However, when assessing the additional benefit that CA125 gives to the ultrasound 
diagnosis our results did not show any benefit.  This was partly because all of the 
stage 3 and 4 disease was correctly diagnosed by TVS and therefore the CA125 level 
could not improve on the false negative rate for stage 3 and 4 disease.  It was also due 
to the fact that the CA125 levels in patients with stage 1 and 2 disease was not 
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statistically higher than CA125 levels for patients with no endometriosis (P= 0.056).  
There was also significant overlap in the ranges of the CA125 results for these two 
groups.  This agrees with the results of the Mol meta-analysis which showed a poor 
ability to exclude the absence of endometriosis with CA125.  
 
One study which has shown promise in excluding endometriosis on a serum test is by 
Mihalyi72 .  In this cohort study they tested for IL6 and 8, tumour necrosis factor-
alpha, high-sensitivity C-reactive protein (hsCRP), and cancer antigens CA-125 and 
CA-19-9.  Using stepwise logistic regression, moderate–severe endometriosis was 
diagnosed with a sensitivity of 100% (specificity 84%) and minimal–mild 
endometriosis was detected with a sensitivity of 87% (specificity 71%) during the 
secretory phase. Using LSSVM analysis, minimal–mild endometriosis was diagnosed 
with a sensitivity of 94% (specificity 61%) during the secretory phase and with a 
sensitivity of 92% (specificity 63%) during the menstrual phase.  Their aim was to 
provide a test which would have a high sensitivity and moderate specificity therefore 
enabling women without endometriosis to avoid having an invasive laparoscopy 
unnecessarily.  However,  these tests were performed on stored samples and it 
remains to be seen whether these complicated multi-marker models can improve 
patient management in a clinical setting.   
 
Conclusions 
This study has shown that CA125 levels are associated with the presence and stage of 
endometriosis at laparoscopy.   However the diagnostic accuracy of TVS is not 
improved by the addition of CA125 to the model.  The numbers in this study were 
small and further investigation is needed to establish if the difference between CA125 
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levels in the mid proliferative phase and menstrual phase of the cycle, or a multi 
marker test with a sophisticated statistical model, could improve on the differentiation 
between patients who have no disease and those who have early or advanced disease.   
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Chapter 11: Conclusions and further research 
 
The main aim of this thesis was to show that targeted transvaginal ultrasound (TVS) 
has the potential to correctly distinguish moderate and severe endometriosis from 
minimal or mild.  This would enable accurate triaging of patients with severe disease 
to specialist centres where advanced level surgery enabling complete excision would 
be possible, without the need for unnecessary diagnostic surgery. This may also 
reduce the long delay that many women experience between the onset of symptoms 
and receiving effective treatment. This thesis was successful in showing in studies 1-3 
that TVS, when performed by ultrasound operators with the appropriate experience, is 
an accurate and reproducible method for diagnosing moderate and severe disease and 
therefore enabling the successful triaging of patients.  The research methods were in 
agreement with the STARD criteria for diagnostic tests132. 
The other benefits to the patient of this ability are: to guide patient choice regarding 
medical or surgical treatment; to plan fertility or medical treatment if surgery is not 
chosen; to enable referral to the most appropriate centre and surgeon if surgery is 
chosen; to enable the surgeon to counsel the patient about the likely extent of surgery 
and potential risks; and to allow the surgeon to prepare sufficiently for surgery 
including the involvement of other specialties as indicated. 
Further research would be helpful to validate these findings in different clinical 
settings with larger numbers of patients and different patient populations.  Future 
research would also be helpful to show that patient outcomes are improved by the 
application of ultrasound based triaging in terms of time interval to definitive 
treatment, reduction in diagnostic laparoscopy, patient satisfaction with the treatments 
offered and cost effectiveness.   
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However although it is possible to accurately diagnose moderate and severe 
endometriosis using TVS the accuracy for diagnosing minimal and mild 
endometriosis is poor.  This is due to the fact that superficial peritoneal deposits of 
endometriosis are too small to see on ultrasound. Currently laparoscopy would be the 
only was to assess these patients which is expensive, has risks and causes 
inconvenience and pain.  Therefore the secondary aim of this thesis was to assess if it 
is possible to add any tests or aspects from the history in order to improve the 
diagnosis of minimal or mild endometriosis either on their own or in conjunction with 
TVS.   In this respect the thesis was less successful than in the primary aim. 
In study 4 symptomatology was assessed and this showed that although the frequency 
of some symptoms increases with increasing severity there is significant overlap in 
symptomatology between patients with no endometriosis and patients with severe 
endoemtriosis.  This means that symptomatology alone can only give a suggestion of 
the presence of disease but in not reliable.  When symptoms were added to the 
assessment of patients who did not have endometriosis found on TVS there was no 
additional benefit found.   
Further research into the severity of the symptoms with larger numbers of patients and 
a more accurate description of their symptoms including visual analogue scores for 
severity may further our understanding of the benefit of the symptomatology on its 
own and as an addition to ultrasound.    
Study 5 assess if the inclusion in the model of serum CA125 levels with TVS would 
be helpful.  I found that although serum CA125 levels as associated with the presence 
and stage of endometriosis at laparoscopy the diagnostic accuracy of TVS is not 
improved by the addition of CA125 to the model.  The numbers in this study were 
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small and further investigation is needed to establish if the difference between CA125 
levels in the mid proliferative phase and menstrual phase of the cycle, or a multi 
marker test with a sophisticated statistical model, could improve on the differentiation 
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Patient information sheet Version 3 dated Dec 2006 
 
Please take some time to read this information sheet.  You might need to 
discuss its content during your consultation.  
 
1. Study title 
The accuracy of gynaecological ultrasound examination for the diagnosis of 
severe pelvic endometriosis. 
 
2. Invitation paragraph 
 
You are being invited to take part in a research study. Before you decide it is 
important for you to understand why the research is being done and what it 
will involve.  Please take time to read the following information carefully and 
discuss it with friends, relatives and your GP if you wish. Ask us if there is 
anything that is not clear or if you would like more information. Take time to 
decide whether or not you wish to take part. 
 
Consumers for Ethics in Research (CERES) publish a leaflet entitled ‘Medical 
Research and You’.  This leaflet gives more information about medical 
research and looks at some questions you may want to ask.  A copy may be 
obtained from CERES, PO Box 1365, LONDON, N16 0BW. 
 
3. What is the purpose of the study? 
To assess the accuracy of diagnosing severe endometriosis on pelvic 
ultrasound scan. Women who have been referred to hospital with features of 
endometriosis such as heavy periods, pelvic pain, reduced fertility and pain 
with sexual intercourse will be investigated for pelvic endometriosis. This often  
involves an ultrasound scan and a diagnostic laparoscopy. If from your history 
your symptoms are suggestive of endometriosis you will be offered the 
opportunity to take part in a study investigating the accuracy of ultrasound in 
the diagnosis of severe endometriosis. Those women who join the study will 
be offered a specialist ultrasound scan performed by an expert in this area 
who will record detailed scan findings prior to the laparoscopy. A blood test 
will also be performed just after your period starts. By comparing the detailed 
ultrasound findings and blood test results with the findings at the operations 
the accuracy of the ultrasound scans can be calculated. More accurate tests 
help patients and their Doctors plan their care better. 
 
4. Why have I been chosen? 
 
You have been referred to this hospital with some of the features of 
endometriosis such as heavy periods, pelvic pain, reduced fertility and pain 
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with sexual intercourse.  Based on your symptoms and an examination you 
have been offered an operation to help in the diagnosis and treatment of your 
symptoms. An expert ultrasound scan and blood tests will be performed to 
look for any signs of endometriosis in the pelvis. The operative findings can 
be compared to the ultrasound scan findings to assess the accuracy of the 
ultrasound scan findings.  
 
5. Do I have to take part? 
 
It is up to you to decide whether or not to take part in the study.  If you do 
decide to take part you will be given this information sheet to keep and be 
asked to sign a consent form.  If you decide to take part you are still free to 
withdraw at any time and without giving a reason.  This will not affect the 
standard of care you receive. 
 
6. What will happen to me if I take part?  
 
The research will take part from January 2006 until February 2008.  You will 
be taking part in an observational study.  This means that your care will not 
change whether you chose to take part in the study or not. All patients taking 
part will be offered an ultrasound examination at King’s College Hospital prior 
to their operation. In addition a blood sample will be taken during early 
menstruation. Thereafter, your care will be followed up during your hospital 
stay or at another clinic appointment. 
 
7. What do I have to do? 
 
By participating in this study, you will not have any additional responsibilities. 
However, you are required to follow any relevant information regarding your 
treatment, which will be given to you at the assessment clinic. Your recovery 
period, following surgical intervention, can vary from 1 week to 2 weeks. 
 
 
8. What is the procedure that is being tested? 
 
We are testing the accuracy of ultrasound scanning and a blood test at 
detecting the severity of endometriosis.  
 
9. What are the alternatives for diagnosis or treatment? 
 
An ultrasound scan is usually the first method of investigation when there is 
suspicion of endometriosis.  There are many alternatives for treatment 
including contraceptives (such as the pill, certain types of coil and other 
contraceptions which help with period pain) and non contraceptive medicines 
including tablets and injections.  This will be discussed with you in more detail 
by your gynaecologist. 
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10. What are the side effects of taking part? 
 
You should not expect to have side effects by taking part in this study. 
Ultrasound scanning is safe and radiation-free.  Taking part in the study will 
not change your care in any way.  We will simply be recording your care in 
slightly more detail than normal in order to help improve the care we can offer. 
 
11. What are the possible disadvantages and risks of taking part? 
 
There are no disadvantages to taking part in this study. 
  
12. What are the possible benefits of taking part? 
 
There are no direct advantages to taking part in the study but you will be 
making a contribution to medical science.  This should lead to improvements 
in care in the future. 
 
13. What if new information becomes available? 
 
Sometimes during the course of a research project, new information becomes 
available about the method that is being studied.  If this happens, your 
research doctor will tell you about it and discuss with you whether you want to 
continue in the study. If you decide to withdraw, your research doctor will 
make arrangements for your care to discontinue. If you decide to discontinue 
in the study, you will be asked to sign an updated consent form. 
 
Also, on receiving new information your research doctor might consider it to 
be in your best interests to withdraw from the study. These reasons will be 
explained and arrange for your care to discontinue. An analysis of the data 
collected will be carried out after one year of starting, to monitor the efficiency 
of the study. 
 
14. What happens when the research study stops? 
 
The study is planned to terminate in February 2008. The findings and 
recommendations will be discussed and published in a medical journal. If the 
research stops earlier than planned, for reasons out of our control, your future 
care will not be affected.  
 
15. What if something goes wrong? 
 
It is not anticipated that this would directly result in harm being caused to any 
patients.  If you are harmed due to someone’s negligence, then you may have 
grounds for a legal action but you may have to pay for it.  Regardless of this, if 
you wish to make a complaint about any aspect of the way you have been 
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approached or treated during the course of this study, the National Health 
Service complaints procedure will be made available to you. 
 
16. Will my taking part in this study be kept confidential? 
 
We will inform your General Practitioner of your participation in the study 
unless instructed otherwise by you. All information collected about you during 
the course of the study will be kept strictly confidential. The data will be stored 
on password-protected computers in a locked room. Any information, which 
leaves the hospital, will have your personal details removed, so your identity 
cannot be recognised. 
 
 
17. What will happen to the results of the research study? 
 
The results of the study will be discussed and analysed to make 
recommendations. We are hoping to publish the outcome of this research by 
December 2008 in a medical journal. Your identity will not be disclosed in any 
publication.  
 
18. Who is organising and funding the research? 
 
The study is funded by the Departments of Obstetrics and Gynaecology at 
King’s College Hospital. 
 
19. Who has reviewed the study? 
 
Research & Development and Research Ethics Committee at Kings College 
Hospital. 
 
20. Contact for further information 
 
Should you need further information about the study, please do not hesitate to 
contact me at the following address:  
 
Dr Tom Holland,  
Suite 8, 3rd floor,  
Golden Jubilee Wing,  
King’s College Hospital,  






Thank you for taking part in this study. 
 
 
A copy of the information sheet and a signed consent for participating in the 










King’s College Hospital 
Consent Form for Diagnosis of severity of endometriosis study 
Patient agreement to study participation 
Patient details 
 Patient’s surname/family name……………………… 
 Patient’s first names  ………………………………… 
 Date of birth    ………………………………………… 
 Responsible health professional 
 Job title ……………………   ………………………… 
 NHS number (or other identifier)……………………. 
  Female 
 
 Special requirements……………………………………… 
 (e.g. other language/other communication method) 
 
One copy to be retained in patient’s notes 





Centre number: ………………… 
Study number:  ………………… 
Patient Identifier number     NB Three copies should be made, for 
 For this trial: …………………  (1) patient, (2) researcher, (3) hospital  
       notes 
 
Title of Project:  
The accuracy of gynaecological ultrasound examination for the diagnosis of 
severe pelvic endometriosis. 
 
Name of Researcher: Tom Holland 
 
         Please initial box 
1. I confirm that I have read and understand the information 
sheet dated  June 2006 (version 2.) for the study “the accuracy of  
gynaecological ultrasound examination for the diagnosis of severe  
pelvic endometriosis” and have had the opportunity to ask questions.  
 
2. I understand that my participation is voluntary and that I   
am free to withdraw at any time, without giving any  
reason, without my medical care or legal rights being affected. 
 
3. I understand that sections of any of my medical notes may  
be looked at by responsible individuals from Kings College Hospital  
or from regulatory authorities where it is relevant to my taking  
part in research. I give permission for these individuals to have 
access to my records. 
 
4. I understand that a blood sample will be kept to be used for research 
 into the diagnosis of pelvic pain and endometriosis. 
 





Name of Patient   Date    Signature 
 
 




Researcher   Date    Signature 
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Serum markers blood form 
 
 
king’s clinical biochemistry - trial form 






































 (Save 5 serum aliquots in freezer) 
DATE TIME NAME BLEEP No. 
 
 






Ethical committee approval 
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